ITEM 1. FINANCIAL STATEMENTS
FORWARD INDUSTRIES, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
|
|
March 31,
|
|
|
September 30,
|
|
|
|
2020
|
|
|
2019
|
|
|
|
(Unaudited)
|
|
|
(Note 1)
|
|
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current assets:
|
|
|
|
|
|
|
|
|
Cash
|
|
$
|
1,348,099
|
|
|
$
|
3,092,813
|
|
Accounts receivable, net
|
|
|
7,368,884
|
|
|
|
6,695,120
|
|
Inventories
|
|
|
636,052
|
|
|
|
1,608,827
|
|
Prepaid expenses and other current assets
|
|
|
609,903
|
|
|
|
441,502
|
|
|
|
|
|
|
|
|
|
|
Total current assets
|
|
|
9,962,938
|
|
|
|
11,838,262
|
|
|
|
|
|
|
|
|
|
|
Property and equipment, net
|
|
|
213,181
|
|
|
|
243,002
|
|
Intangible assets, net
|
|
|
1,167,030
|
|
|
|
1,248,712
|
|
Goodwill
|
|
|
1,167,427
|
|
|
|
2,182,427
|
|
Investment
|
|
|
–
|
|
|
|
326,941
|
|
Operating lease right of use assets, net
|
|
|
3,490,049
|
|
|
|
–
|
|
Other assets
|
|
|
184,201
|
|
|
|
255,008
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
16,184,826
|
|
|
$
|
16,094,352
|
|
|
|
|
|
|
|
|
|
|
Liabilities and shareholders' equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current liabilities:
|
|
|
|
|
|
|
|
|
Line of credit
|
|
$
|
400,000
|
|
|
$
|
1,300,000
|
|
Accounts payable
|
|
|
258,442
|
|
|
|
315,444
|
|
Due to Forward China
|
|
|
2,307,759
|
|
|
|
3,236,693
|
|
Deferred income
|
|
|
707,987
|
|
|
|
219,831
|
|
Notes payable
|
|
|
1,608,125
|
|
|
|
1,654,799
|
|
Capital leases payable - short-term portion
|
|
|
39,306
|
|
|
|
39,941
|
|
Deferred consideration
|
|
|
293,000
|
|
|
|
834,000
|
|
Operating lease liability - short-term portion
|
|
|
255,505
|
|
|
|
–
|
|
Accrued expenses and other current liabilities
|
|
|
642,516
|
|
|
|
694,972
|
|
Total current liabilities
|
|
|
6,512,640
|
|
|
|
8,295,680
|
|
|
|
|
|
|
|
|
|
|
Other liabilities:
|
|
|
|
|
|
|
|
|
Capital leases payable - long-term portion
|
|
|
10,585
|
|
|
|
26,438
|
|
Deferred rent
|
|
|
–
|
|
|
|
60,935
|
|
Operating lease liability - long-term portion
|
|
|
3,334,134
|
|
|
|
–
|
|
Total other liabilities
|
|
|
3,344,719
|
|
|
|
87,373
|
|
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
|
9,857,359
|
|
|
|
8,383,053
|
|
|
|
|
|
|
|
|
|
|
Commitments and contingencies
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shareholders' equity:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock, par value $0.01 per share; 40,000,000 shares authorized; 9,533,851 shares issued and outstanding
|
|
|
95,338
|
|
|
|
95,338
|
|
Additional paid-in capital
|
|
|
19,005,569
|
|
|
|
18,936,130
|
|
Accumulated deficit
|
|
|
(12,773,440
|
)
|
|
|
(11,320,169
|
)
|
|
|
|
|
|
|
|
|
|
Total shareholders' equity
|
|
|
6,327,467
|
|
|
|
7,711,299
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and shareholders' equity
|
|
$
|
16,184,826
|
|
|
$
|
16,094,352
|
|
The accompanying notes are an integral part of the unaudited
condensed consolidated financial statements.
FORWARD INDUSTRIES, INC. AND SUBSIDIARIES
CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
(UNAUDITED)
|
|
For the Three Months
Ended March 31,
|
|
|
For the Six Months
Ended March 31,
|
|
|
|
2020
|
|
|
2019
|
|
|
2020
|
|
|
2019
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Revenues
|
|
$
|
7,931,377
|
|
|
$
|
8,172,467
|
|
|
$
|
16,324,231
|
|
|
$
|
18,355,750
|
|
Cost of Sales
|
|
|
6,478,228
|
|
|
|
6,861,622
|
|
|
|
13,151,073
|
|
|
|
15,741,864
|
|
Gross Profit
|
|
|
1,453,149
|
|
|
|
1,310,845
|
|
|
|
3,173,158
|
|
|
|
2,613,886
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales and marketing
|
|
|
479,461
|
|
|
|
428,376
|
|
|
|
1,014,633
|
|
|
|
897,975
|
|
General and administrative
|
|
|
1,625,385
|
|
|
|
1,957,530
|
|
|
|
2,839,351
|
|
|
|
3,271,499
|
|
Goodwill impairment
|
|
|
1,015,000
|
|
|
|
–
|
|
|
|
1,015,000
|
|
|
|
–
|
|
Total operating expenses
|
|
|
3,119,846
|
|
|
|
2,385,906
|
|
|
|
4,868,984
|
|
|
|
4,169,474
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from operations
|
|
|
(1,666,697
|
)
|
|
|
(1,075,061
|
)
|
|
|
(1,695,826
|
)
|
|
|
(1,555,588
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other income (expenses):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value adjustment of earn-out consideration
|
|
|
350,000
|
|
|
|
–
|
|
|
|
350,000
|
|
|
|
–
|
|
Fair value adjustment of deferred cash consideration
|
|
|
(9,000
|
)
|
|
|
–
|
|
|
|
(9,000
|
)
|
|
|
–
|
|
Interest expense
|
|
|
(44,178
|
)
|
|
|
(53,051
|
)
|
|
|
(95,127
|
)
|
|
|
(98,088
|
)
|
Other expense
|
|
|
(1,739
|
)
|
|
|
(2,793
|
)
|
|
|
(3,318
|
)
|
|
|
(7,756
|
)
|
Total Other income (expense)
|
|
|
295,083
|
|
|
|
(55,844
|
)
|
|
|
242,555
|
|
|
|
(105,844
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Loss
|
|
$
|
(1,371,614
|
)
|
|
$
|
(1,130,905
|
)
|
|
$
|
(1,453,271
|
)
|
|
$
|
(1,661,432
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss per basic common share
|
|
$
|
(0.14
|
)
|
|
$
|
(0.12
|
)
|
|
$
|
(0.15
|
)
|
|
$
|
(0.17
|
)
|
Net loss per diluted common share
|
|
$
|
(0.14
|
)
|
|
$
|
(0.12
|
)
|
|
$
|
(0.15
|
)
|
|
$
|
(0.17
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of common and common equivalent shares outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
9,533,851
|
|
|
|
9,532,645
|
|
|
|
9,533,851
|
|
|
|
9,530,207
|
|
Diluted
|
|
|
9,533,851
|
|
|
|
9,532,645
|
|
|
|
9,533,851
|
|
|
|
9,530,207
|
|
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
FORWARD INDUSTRIES, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY
(UNAUDITED)
|
|
|
|
|
Additional
|
|
|
|
|
|
|
Common Stock
|
|
Paid-In
|
|
Accumulated
|
|
|
|
|
Shares
|
|
Amount
|
|
Capital
|
|
Deficit
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance - September 30, 2019
|
|
9,533,851
|
|
$
|
95,338
|
|
$
|
18,936,130
|
|
$
|
(11,320,169
|
)
|
$
|
7,711,299
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based compensation
|
|
–
|
|
|
–
|
|
|
33,179
|
|
|
–
|
|
|
33,179
|
|
Net loss
|
|
–
|
|
|
–
|
|
|
–
|
|
|
(81,657
|
)
|
|
(81,657
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance - December 31, 2019
|
|
9,533,851
|
|
|
95,338
|
|
|
18,969,309
|
|
|
(11,401,826
|
)
|
|
7,662,821
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based compensation
|
|
–
|
|
|
–
|
|
|
36,260
|
|
|
–
|
|
|
36,260
|
|
Net loss
|
|
–
|
|
|
–
|
|
|
–
|
|
|
(1,371,614
|
)
|
|
(1,371,614
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance - March 31, 2020
|
|
9,533,851
|
|
$
|
95,338
|
|
$
|
19,005,569
|
|
$
|
(12,773,440
|
)
|
$
|
6,327,467
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance - September 30, 2018
|
|
9,533,851
|
|
$
|
95,338
|
|
$
|
18,720,396
|
|
$
|
(7,716,139
|
)
|
$
|
11,099,595
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based compensation
|
|
–
|
|
|
–
|
|
|
11,794
|
|
|
–
|
|
|
11,794
|
|
Net loss
|
|
–
|
|
|
–
|
|
|
–
|
|
|
(530,527
|
)
|
|
(530,527
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance - December 31, 2018
|
|
9,533,851
|
|
|
95,338
|
|
|
18,732,190
|
|
|
(8,246,666
|
)
|
|
10,580,862
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based compensation
|
|
–
|
|
|
–
|
|
|
136,096
|
|
|
–
|
|
|
136,096
|
|
Net loss
|
|
|
|
|
|
|
|
|
|
|
(1,130,905
|
)
|
|
(1,130,905
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance - March 31, 2019
|
|
9,533,851
|
|
$
|
95,338
|
|
$
|
18,868,286
|
|
$
|
(9,377,571
|
)
|
$
|
9,586,053
|
|
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
FORWARD INDUSTRIES, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
|
|
For the Six Months Ended March
31,
|
|
|
|
2020
|
|
|
2019
|
|
Cash Flows From Operating Activities:
|
|
|
|
|
|
|
|
|
Net loss
|
|
$
|
(1,453,271
|
)
|
|
$
|
(1,661,432
|
)
|
Adjustments to reconcile net loss to net cash used in
operating activities:
|
|
|
|
|
|
|
|
|
Share-based compensation
|
|
|
69,439
|
|
|
|
147,890
|
|
Depreciation and amortization
|
|
|
297,244
|
|
|
|
156,668
|
|
Bad debt expense (recovery)
|
|
|
(109,914
|
)
|
|
|
407,765
|
|
Deferred rent
|
|
|
–
|
|
|
|
1,624
|
|
Change in fair value of earn-out consideration
|
|
|
(350,000
|
)
|
|
|
–
|
|
Change in fair value of deferred cash consideration
|
|
|
9,000
|
|
|
|
–
|
|
Goodwill impairment
|
|
|
1,015,000
|
|
|
|
–
|
|
Impairment of investment
|
|
|
326,941
|
|
|
|
–
|
|
Changes in operating assets and liabilities:
|
|
|
|
|
|
|
|
|
Accounts receivable
|
|
|
(563,850
|
)
|
|
|
794,580
|
|
Inventories
|
|
|
972,775
|
|
|
|
135,745
|
|
Prepaid expenses and other current assets
|
|
|
(168,401
|
)
|
|
|
(366,035
|
)
|
Other assets
|
|
|
70,806
|
|
|
|
(276,518
|
)
|
Accounts payable and due to Forward China
|
|
|
(985,936
|
)
|
|
|
(2,060,530
|
)
|
Deferred income
|
|
|
488,156
|
|
|
|
(54,092
|
)
|
Operating lease liabilities
|
|
|
(139,702
|
)
|
|
|
–
|
|
Accrued expenses and other current liabilities
|
|
|
(32,632
|
)
|
|
|
11,014
|
|
Net cash used in operating activities
|
|
|
(554,345
|
)
|
|
|
(2,763,321
|
)
|
|
|
|
|
|
|
|
|
|
Cash Flows From Investing Activities:
|
|
|
|
|
|
|
|
|
Purchases of property and equipment
|
|
|
(27,207
|
)
|
|
|
(24,178
|
)
|
Net cash used in investing activities
|
|
|
(27,207
|
)
|
|
|
(24,178
|
)
|
|
|
|
|
|
|
|
|
|
Cash Flows From Financing Activities:
|
|
|
|
|
|
|
|
|
Proceeds from line of credit borrowings
|
|
|
200,000
|
|
|
|
1,250,000
|
|
Repayment of line of credit borrowings
|
|
|
(1,100,000
|
)
|
|
|
(300,000
|
)
|
Repayment of notes payable
|
|
|
(46,674
|
)
|
|
|
(120,803
|
)
|
Repayments on capital equipment leases
|
|
|
(16,488
|
)
|
|
|
(25,399
|
)
|
Payment of deferred cash consideration
|
|
|
(200,000
|
)
|
|
|
–
|
|
Net cash provided by (used in) financing activities
|
|
|
(1,163,162
|
)
|
|
|
803,798
|
|
|
|
|
|
|
|
|
|
|
Net decrease in cash
|
|
|
(1,744,714
|
)
|
|
|
(1,983,701
|
)
|
Cash at beginning of period
|
|
|
3,092,813
|
|
|
|
4,369,866
|
|
Cash at end of period
|
|
$
|
1,348,099
|
|
|
$
|
2,386,165
|
|
Supplemental Disclosures of Cash Flow Information:
|
|
|
|
|
|
|
|
|
Cash paid for interest
|
|
$
|
95,127
|
|
|
$
|
66,087
|
|
Cash paid for taxes
|
|
$
|
1,524
|
|
|
$
|
37,859
|
|
|
|
|
|
|
|
|
|
|
Supplemental Disclosures of Non-Cash Information:
|
|
|
|
|
|
|
|
|
ROU assets from the adoption of ASC 842
|
|
$
|
3,648,582
|
|
|
$
|
–
|
|
Lease liabilities arising from obtaining ROU assets
|
|
$
|
3,729,341
|
|
|
$
|
–
|
|
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
FORWARD INDUSTRIES,
INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1 OVERVIEW
Forward Industries,
Inc. (“Forward” or the “Company”) is a fully integrated design, development and manufacturing solution
provider for top tier medical and technology customers worldwide. Through its acquisition of Intelligent Product Solutions, Inc.
(“IPS”), the Company has expanded its ability to design and develop solutions for our existing multinational client
base and expand beyond the diabetic product line into a variety of industries with a full spectrum of hardware and software product
design and engineering services. In addition to our existing design and distribution of carry and protective solutions, primarily
for handheld electronic devices, the Company is now a one-stop shop for design, development and manufacturing solutions serving
a wide range of clients in the industrial, commercial and consumer industries. The Company’s previous principal customer
market has been original equipment manufacturers, or “OEMs” (or the contract manufacturing firms of these OEM customers),
that either package our products as accessories “in box” together with their branded product offerings or sell them
through their retail distribution channels. The Company’s OEM products include carrying cases and other accessories for medical
monitoring and diagnostic kits and a variety of other portable electronic and non-electronic products (such as sporting and recreational
products, bar code scanners, smartphones, GPS location devices, tablets, firearms). The Company’s OEM customers are located
in: (i) the Asia-Pacific Region, which we refer to as the “APAC Region”; (ii) Europe, the Middle East, and Africa,
which we refer to as the “EMEA Region”; and (iii) the Americas. The Company does not manufacture any of its OEM products
and sources substantially all of its OEM products from independent suppliers in China, through Forward China.
As a result of
the expansion of the design development capabilities through its wholly owned subsidiary, IPS (acquired in January 2018), the
Company is now able to introduce proprietary products to the market from concepts brought to it from a number of different
sources, both inside and outside the Company.
In the opinion of
management, the accompanying condensed consolidated financial statements presented in this Quarterly Report on Form 10-Q reflect
all normal recurring adjustments necessary to present fairly the financial position and results of operations and cash flows for
the interim periods presented herein, but are not necessarily indicative of the results of operations for the year ending September
30, 2020. These condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated
financial statements included in its Annual Report on Form 10-K for the fiscal year ended September 30, 2019, and with the disclosures
and risk factors presented therein. The September 30, 2019 condensed consolidated balance sheet has been derived from the audited
consolidated financial statements.
IMPACT OF COVID-19
While the COVID-19
pandemic has had a minimal impact on our financial results through March 31, 2020, the future impacts of the pandemic and any resulting
economic impact are largely unknown and rapidly evolving and could be significant. It is possible that the COVID-19 pandemic, the
measures taken by the governments of countries affected and the resulting economic impact may negatively impact our results of
operations, cash flows and financial position as well as our customers, and their ability to make payment. As a result, the effects
of COVID-19 may not be fully reflected in our financial results until future periods. Refer to “Part II, Item 1A —
Risk Factors” in this Quarterly Report for a description of the material risks that the Company currently faces in connection
with COVID-19. The impact of the COVID-19 pandemic may also exacerbate other risks discussed in “Part I, Item 1A —
Risk Factors” included in the Company’s Annual Report for the year ended September 30, 2019.
As a result of
revenue and earnings shortfall for the 2020 Quarter, due in part to the impact of COVID-19 and the related future
uncertainty, the Company has revised the outlook for the remainder of the year and long-term outlook. This new outlook has
impacted the Company’s carrying value of Goodwill (see Note 4). Looking ahead to the remainder of 2020, our visibility
is limited due to the uncertainty surrounding the duration and ultimate impact of COVID-19 and the mitigation measures that
are implemented by governmental authorities. We also expect business conditions to remain challenging. In response to
these challenges, we will continue to focus on those factors that we can control: closely managing and controlling our
expenses; aligning our design and development schedules with demand in a proactive manner as there are changes in market
conditions to minimize our cash operating costs; and pursuing further improvements in the productivity and effectiveness of
our development, selling and administrative activities.
FORWARD INDUSTRIES,
INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 2 ACCOUNTING
POLICIES
Accounting Estimates
The preparation of
the Company’s condensed consolidated financial statements in conformity with accounting principles generally accepted in
the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the condensed consolidated
financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ
from those estimates and assumptions.
The worldwide spread
of COVID-19 has resulted in a global slowdown of economic activity which is likely to decrease demand for a broad variety of goods
and services, while also disrupting sales channels, marketing activities and general business operations for an unknown period
of time until the disease is contained. At this point, the extent to which COVID-19 may impact our financial condition or results
of operations is uncertain, and as of the date of issuance of these condensed consolidated financial statements, we are not aware
of any specific event or circumstance that would require us to update our estimates, judgments or adjust the carrying value of
our assets or liabilities. These estimates may change, as new events occur and additional information is obtained, and are recognized
in the condensed consolidated financial statements as soon as they become known. Actual results could differ from those estimates
and any such differences may be material to our condensed consolidated financial statements.
Basis of Presentation
The accompanying condensed
consolidated financial statements include the accounts of Forward Industries, Inc. and its wholly-owned subsidiaries (Forward US,
Forward Switzerland, Forward UK and IPS). All significant intercompany transactions and balances have been eliminated in consolidation.
Intercompany revenues of approximately $12,000 and $28,000, respectively, for the three and six months ended March 31, 2020 and
approximately $5,000 and $206,000, respectively, for the three and six months ended March 31, 2019, related to design and marketing
work performed by IPS for Forward have been eliminated in consolidation.
The Company
incurred a net loss of approximately $1.5 million for the six months ended March 31, 2020, generated negative cash flow
from operations of approximately $0.5 million and have an accumulated deficit of approximately $12.8 million as of March 31,
2020. We believe our existing cash balance and working capital will be sufficient to meet our liquidity needs at least through
June 30, 2021.
Segment Reporting
Operating segments
are defined as components of an enterprise about which separate financial information is available that is regularly evaluated
by a chief operating decision maker, or Forward management, in deciding how to allocate resources and in assessing performance.
As a result of the acquisition of IPS in January 2018, management conducts business through two distinct operating segments,
which are also our reportable segments: distribution and design. Forward US, Forward Switzerland and Forward UK comprise the
distribution operating segment and IPS is the design operating segment.
Organizing our business
through two operating segments allows us to align our resources and manage the operations. Our management team regularly reviews
operating segment revenue and profitability when assessing financial results of operating segments and allocating resources.
We measure the performance
of our operating segments based upon operating segment revenue and operating income (loss). Segment operating income (loss) includes
revenue and expenses incurred directly by the operating segment, including cost of sales and selling, marketing, and general and
administrative expenses.
FORWARD INDUSTRIES,
INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 2 ACCOUNTING
POLICIES (Continued)
Goodwill
Goodwill is an asset
representing the future economic benefits arising from other assets acquired in a business combination that are not individually
identified and separately recognized. Goodwill was recognized as a result of the acquisition of IPS in January 2018.
Goodwill is
reviewed for impairment at least annually, and when triggering events occur, in accordance with the provisions of Financial
Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic
350, “Intangibles – Goodwill and Other.” The Company has two reporting units for purposes of
evaluating goodwill impairment and management performs our annual goodwill impairment test on September 30, at the end of the
fiscal year or at interim upon the occurrence of a triggering event. The Company has the option to perform a qualitative
assessment to determine if an impairment is more likely than not to have occurred. If the Company can support the conclusion
that it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, then the
Company would not need to perform the impairment test for the reporting unit. If the Company cannot support such a conclusion
or does not elect to perform the qualitative assessment, then the Company will compare the fair value of the reporting unit
with its carrying amount, including goodwill. During the three months ended March 31, 2020, management revised the
forward-looking projections due to lower than anticipated revenue during the quarter ended March 31, 2020 and the potential
impact of COVID-19 on future periods. As a result of the lower projections, management determined a triggering event had
occurred and undertook a review of the goodwill and intangible assets valuations (see Note 4). Management determined that an
impairment was more likely than not to have occurred. See Note 4 of the Notes to the condensed consolidated financial
statements for more discussion regarding the interim goodwill impairment test. If the fair value of the reporting unit
exceeds its carrying value, no impairment charge is recognized. If the fair value of the reporting unit is less than its
carrying value, an impairment charge will be recognized for the amount by which the reporting unit’s carrying amount
exceeds its fair value. A significant amount of judgment is required in performing goodwill impairment tests including
estimating the fair value of a reporting unit and the implied fair value of goodwill.
Intangible Assets
Intangible assets
include trademark and customer relationships, which were acquired as part of the acquisition of IPS in January 2018 and are recorded
based on the estimated fair value in purchase price allocation. The intangible assets are amortized over their estimated useful
lives, which are periodically evaluated for reasonableness.
Our intangible assets
are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be
recoverable. In assessing the recoverability of our intangible assets, we must make estimates and assumptions regarding future
cash flows and other factors to determine the fair value of the respective assets. These estimates and assumptions could have a
significant impact on whether an impairment charge is recognized and also the magnitude of any such charge. Fair value estimates
are made at a specific point in time, based on relevant information. These estimates are subjective in nature and involve uncertainties
and matters of significant judgments and therefore cannot be determined with precision. Changes in assumptions could significantly
affect the estimates. If these estimates or material related assumptions change in the future, we may be required to record impairment
charges related to our intangible assets. Management evaluated and concluded that there were no impairments of intangible assets
at March 31, 2020.
Income Taxes
The Company recognizes
future tax benefits and liabilities measured at enacted rates attributable to temporary differences between financial statement
and income tax bases of assets and liabilities and to net tax operating loss carryforwards to the extent that realization of these
benefits is more likely than not. As of March 31, 2020, there was no change to our assessment that a full valuation allowance was
required against all net deferred tax assets as it is not probable that such deferred tax assets will be realized. Accordingly,
any deferred tax provision or benefit was offset by an equal and opposite change to the valuation allowance. No current book income
tax provision was recorded against book net income due to the existence of significant net operating loss carryforwards.
FORWARD INDUSTRIES,
INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 2 ACCOUNTING
POLICIES (Continued)
Revenue Recognition
Distribution Segment
The Company generally
recognizes revenue in its distribution segment when: (i) finished goods are shipped to our distribution customers (in general,
these conditions occur at either point of shipment or point of destination, depending on the terms of sale, i.e., transfer of control);
(ii) there are no other deliverables or performance obligations; and (iii) there are no further obligations to the customer after
the title of the goods has transferred. The Company defers revenue, contract liabilities, when it receives consideration before
achieving the criteria previously mentioned. As of March 31, 2020 and September 30, 2019, there were no contract liabilities relating
to the distribution segment.
Design Segment
Under ASC 606, the
Company applies the “cost to cost” and “right to invoice” methods of revenue recognition to the contracts
with customers in the design segment. The design segment typically engages in two types of contracts: (i) Time and Material and
(ii) Fixed Price contracts. The Company recognizes revenue over time on its time and material contracts utilizing a “right
to invoice” method. Revenues from fixed price contracts that require performance of services that are not related to the
production of tangible assets are recognized by using cost inputs to measure progress toward the completion of its performance
obligations or the “cost to cost” method. Revenues from contracts that contain specific deliverables are recognized
when the performance obligation has been satisfied or the transfer of goods to the customer has been completed and accepted.
Recognized revenues
that will not be billed until a later date, or Contract assets, are recorded as an asset and classified as a component of accounts
receivable in the accompanying condensed consolidated balance sheets. Contract assets at March 31, 2020 and September 30, 2019
were approximately $711,000 and $611,000, respectively. Contracts where collections to date have exceeded recognized revenues,
or Contract liabilities, are recorded as a liability and classified as a component of deferred income in the accompanying condensed
consolidated balance sheets. Contract liabilities at March 31, 2020 and September 30, 2019 were approximately $708,000 and $220,000,
respectively.
Share-Based Compensation
Expense
The Company recognizes
employee and director share-based compensation in its condensed consolidated statements of operations and comprehensive loss at
the grant date based on the fair value of stock options and other equity based compensation. The determination of stock option
grant date fair value is estimated using the Black-Scholes option pricing model, which includes variables such as the expected
volatility of the Company’s share price, the exercise behavior of its grantees, interest rates, and dividend yields. These
variables are projected based on the Company’s historical data, experience, and other factors. In the case of awards with
multiple vesting periods, the Company has elected to use the graded vesting attribution method, which recognizes compensation
cost on a straight-line basis over each separately vesting portion of the award as if the award was, in substance, multiple awards.
See Note 6 - Share-Based Compensation. In addition, the Company recognizes share-based compensation to non-employees based upon
the fair value, using the Black-Scholes option pricing model, determined at the deemed measurement dates over the related contract
service period.
FORWARD INDUSTRIES,
INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 2 ACCOUNTING
POLICIES (Continued)
Recent Accounting
Pronouncements
In May 2014, the FASB
issued Accounting Standards Update (“ASU”) No. 2014-09, “Revenue from Contracts with Customers,” (“ASU
2014-09”). ASU 2014-09 supersedes the revenue recognition requirements in ASC 605, “Revenue Recognition” (“ASC
605”) and most industry-specific guidance throughout ASC 605. ASU 2014-09 establishes principles for recognizing revenue
upon the transfer of promised goods or services to customers, in an amount that reflects the expected consideration received in
exchange for those goods or services. The guidance in ASU 2014-09 was revised in July 2015 to be effective for interim periods
beginning on or after December 15, 2017 and should be applied on a transitional basis either retrospectively to each prior reporting
period presented or retrospectively with the cumulative effect of initially applying ASU 2014-09 recognized at the date of initial
application. In 2016, FASB issued additional ASUs that clarify the implementation guidance on principal versus agent considerations
(ASU 2016-08), on identifying performance obligations and licensing (ASU 2016-10), and on narrow-scope improvements and practical
expedients (ASU 2016-12) as well as on the revenue recognition criteria and other technical corrections (ASU 2016-20). These new
standards became effective during the first quarter of fiscal 2019 and were adopted using the modified retrospective method. The
Company has performed a review of ASU 2014-09 as compared to its previous accounting policies for our products and services revenues
and did not identify any material impact to revenue. Therefore, there was no adjustment to retained earnings for a cumulative effect.
Effective October
1, 2018, the Company adopted ASC 606 and elected the modified retrospective method on existing contracts at the date of adoption.
The Company has implemented the necessary changes to such business processes, controls and systems to effectively review and account
for the new contracts under this standard.
Revenues recognized
from the distribution segment under ASC 606 are consistent with previous revenue recognition standards under ASC 605, whereby revenue
is typically recognized at either the point of shipment or point of destination, depending on the terms of the sale.
Regarding the Company’s
design segment, the Company has evaluated the changes from adopting this new standard on its financial reporting, disclosures and
its various revenue streams. The Company now recognizes revenue over time on its time and material contracts utilizing a “right
to invoice” method which is similar to previous revenue recognition standards under ASC 605. Revenues from fixed-price type
contracts that require performance of services that are not related to the production of tangible assets are recognized by using
cost inputs to measure progress toward the completion of its performance obligations. This method is similar to the method formerly
applied to certain of the Company’s contracts covered by the previous revenue recognition standards under ASC 605. In some
cases, contracts contain an arrangement of specific deliverables or production of prototypes, or a distinct performance obligation,
and the Company allocates the transaction price to the performance obligation on a relative standalone selling price basis.
In February 2016,
the FASB issued a new standard related to leases to increase transparency and comparability among organizations by requiring the
recognition of operating lease right-of-use (“ROU”) assets and lease liabilities on the balance sheet. Most prominent
among the changes in the standard is the recognition of ROU assets and lease liabilities by lessees for those leases classified
as operating leases. Under the standard, disclosures are required to meet the objective of enabling users of financial statements
to assess the amount, timing, and uncertainty of cash flows arising from leases. The Company is also required to recognize and
measure new leases at the adoption date and recognize a cumulative-effect adjustment in the period of adoption using a modified
retrospective approach, with certain practical expedients available.
The Company adopted
Accounting Standards Codification ("ASC") 842, "Leases" ("ASC 842") effective October 1, 2019 and
elected to apply the available practical expedients and implemented internal controls and key system functionality to enable the
preparation of financial information on adoption. The Company elected the practical expedients that allow the Company to carry
forward the historical lease classification. At adoption, the Company elected the following practical expedients: (1) the "package
of practical expedients", pursuant to which the Company did not need to reassess its prior conclusions about lease identification,
lease classification and initial direct costs, (2) creation of an accounting policy for short-term leases resulting in lease payments
being recorded as an expense on a straight-line basisover the lease term, and (3) to account separately for lease and non-lease
components for all leases. The Company has established an inventory of existing leases and implemented a new process of evaluating
the classification of each lease. The financial impact of the adoption primarily relates to the capitalization of right-of-use
assets and recognition of lease liability related to operating leases.
FORWARD INDUSTRIES,
INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 2 ACCOUNTING
POLICIES (Continued)
In the first quarter
of 2019, the Company adopted FASB ASU No. 2016-16, “Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than
Inventory” (“ASU 2016-16”), which requires the recognition of the income tax consequences of an intra-entity
transfer of an asset, other than inventory, when the transfer occurs. The adoption of ASU 2016-16 did not have an impact to the
condensed consolidated financial statements due to the Company’s maintenance of a full valuation allowance on the Company’s
net deferred tax asset.
In January 2017,
the FASB issued ASU 2017-04, “Intangibles - Goodwill and Other (Topic 350) - Simplifying the Test for Goodwill Impairment.”
ASU 2017-04 simplifies the accounting for goodwill impairments by eliminating the requirement to compare the implied fair value
of goodwill with its carrying amount as part of step two of the goodwill impairment test referenced in ASC 350, “Intangibles
- Goodwill and Other (“ASC 350”).” As a result, an entity should perform its annual, or interim, goodwill
impairment test by comparing the fair value of a reporting unit with its carrying amount. An impairment charge should be recognized
for the amount by which the carrying amount exceeds the reporting unit’s fair value. However, the impairment loss recognized
should not exceed the total amount of goodwill allocated to that reporting unit. ASU 2017-04 is effective for annual reporting
periods beginning after December 15, 2019, including any interim impairment tests within those annual periods, with early application
permitted for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017. The Company adopted
ASU 2017-04 in the first quarter of Fiscal 2019 and the adoption did not have any impact on the Company’s condensed consolidated
financial statements.
In May 2017, the
FASB issued ASU No. 2017-09, “Scope of Modification Accounting”, to provide guidance on which changes to the
terms or conditions of a share-based payment award require an entity to apply modification accounting. The Company adopted ASU
No. 2017-09 in the first quarter of Fiscal 2019 and the adoption did not have any impact on the Company’s condensed consolidated
financial statements.
In March 2018,
the FASB issued ASU 2018-05, “Income Taxes (Topic 740), Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting
Bulletin No. 118.” The ASU adds various Securities and Exchange Commission (“SEC”) paragraphs pursuant to
the issuance of the December 2017 SEC Staff Accounting Bulletin No. 118, “Income Tax Accounting Implications of the Tax
Cuts and Jobs Act (“SAB 118”)”, which was effective immediately. The SEC issued SAB 118 to address concerns
about reporting entities’ ability to timely comply with the accounting requirements to recognize all of the effects of
the Tax Cuts and Jobs Act in the period of enactment. SAB 118 allows disclosure that determination of some or all of the
income tax effects from the Tax Cuts and Jobs Act may be incomplete by the due date of the condensed consolidated financial
statements and, if possible, provide a reasonable estimate. The Company has accounted for the tax effects of the Tax Cuts and
Jobs Act under the guidance of SAB 118.
In June 2018, the
FASB issued ASU 2018-07, “Compensation — Stock Compensation (Topic 718),” (“ASU 2018-07”). ASU 2018-07
is intended to reduce cost and complexity and to improve financial reporting for nonemployee share-based payments. The accounting
requirements for nonemployee and employee share-based payment transactions had previously been significantly different. ASU 2018-07
expands the scope of Topic 718, “Compensation — Stock Compensation” (which currently only includes share-based
payments to employees) to include share-based payments issued to nonemployees for goods or services. Consequently, the accounting
for share-based payments to nonemployees and employees will be substantially aligned. This ASU supersedes Subtopic 505-50, “Equity
— Equity-Based Payments to Nonemployees.” The amendments in this ASU are effective for fiscal years beginning after
December 15, 2018, and interim periods within that fiscal year. Early adoption is permitted, but no earlier than a company’s
adoption date of Topic 606, “Revenue from Contracts with Customers.” The Company adopted ASU 2018-07 effective October
1, 2019. The adoption of ASU 2018-07 did not have a material impact on the Company’s condensed consolidated financial statements.
In August 2018, the
FASB issued ASU 2018-13, “Fair Value Measurement - Disclosure Framework (Topic 820).” The updated guidance improves
the disclosure requirements on fair value measurements. The updated guidance is effective for fiscal years, and interim periods
within those fiscal years, beginning after December 15, 2019. Early adoption is permitted for any removed or modified disclosures.
The Company is currently assessing the timing and impact of adopting the updated provisions.
FORWARD INDUSTRIES,
INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 2 ACCOUNTING
POLICIES (Continued)
In November 2019,
the FASB issued ASU 2019-08, “Compensation – Stock Compensation (Topic 718) and Revenue from Contracts with Customers
(Topic 606).” ASU 2019-08 is an accounting pronouncement which expands the scope of ASC Topic 718 to provide guidance for
share-based payment awards granted to a customer in conjunction with selling goods or services accounted for under Topic 606. The
pronouncement is effective for fiscal years beginning after December 15, 2019 and interim periods within those fiscal years. The
Company is currently evaluating the effects of this pronouncement on its condensed consolidated financial statements along with
the effects of ASU 2018-07 noted above.
In November 2019,
the FASB issued ASU 2019-11, “Codification Improvements to Topic 326, Financial Instruments – Credit Losses.”
ASU 2019-11 is an accounting pronouncement that amends ASU 2016-13, “Financial Instruments – Credit Losses (Topic
326): Measurement of Credit Losses on Financial Instruments.” The ASU 2019-11 amendment provides clarity and improves the
codification to ASU 2016-03. The pronouncement would be effective concurrently with the adoption of ASU 2016-03. The pronouncement
is effective for fiscal years beginning after December 15, 2019 and interim periods within those fiscal years. The Company is
currently evaluating the effects of this pronouncement on its condensed consolidated financial statements.
Business Combinations
The Company allocates
the fair value of purchase consideration to the tangible assets acquired, liabilities assumed and intangible assets acquired based
on their estimated fair values. The excess of the purchase consideration over the fair values of these identifiable assets and
liabilities is recorded as goodwill. When determining the fair values of assets acquired and liabilities assumed, the Company makes
significant estimates and assumptions, especially with respect to intangible assets.
The Company recognizes
the purchase of assets and the assumption of liabilities as an asset acquisition, if the transaction does not constitute a business
combination. The excess of the fair value of the purchase price is allocated on a relative fair value basis to the identifiable
assets and liabilities. No goodwill is recorded in an asset acquisition.
Critical estimates
in valuing certain intangible assets include but are not limited to future expected cash flows from customer relationships and
developed technology, discount rates and terminal values. Our estimate of fair value is based upon assumptions believed to be reasonable,
but actual results may differ from estimates.
Other estimates associated
with the accounting for acquisitions may change as additional information becomes available regarding the assets acquired and liabilities
assumed.
NOTE 3 FAIR VALUE
MEASUREMENTS
We perform fair value
measurements in accordance with the guidance provided by ASC 820. ASC 820 defines fair value as the price that would be received
from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement
date. When determining the fair value measurements for assets and liabilities required to be recorded at their fair values, we
consider the principal or most advantageous market in which we would transact and consider assumptions that market participants
would use when pricing the assets or liabilities, such as inherent risk, transfer restrictions, and risk of nonperformance.
FORWARD INDUSTRIES,
INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 3 FAIR
VALUE MEASUREMENTS
ASC 820 establishes
a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs
when measuring fair value. An asset’s or liability’s categorization within the fair value hierarchy is based upon the
lowest level of input that is significant to the fair value measurement. ASC 820 establishes three levels of inputs that may be
used to measure fair value:
• Level
1: quoted prices in active markets for identical assets or liabilities;
• Level 2: inputs other
than Level 1 that are observable, either directly or indirectly, such as quoted prices in active markets for similar assets or
liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that
are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; or
• Level 3: unobservable
inputs that are supported by little or no market activity and that are significant to the fair values of the assets or liabilities.
The deferred compensation
of $293,000 on our condensed consolidated balance sheets as of March 31, 2020 is the present value of a $300,000 payment due on
September 30, 2020 per the Stock Purchase Agreement as part of the acquisition price of IPS. The earn-out consideration portion
was adjusted down in the 2020 Quarter from a fair value of $350,000 to $0 due to the low likelihood of reaching the EBITDA targets
as outlined in the Stock Purchase Agreement.
The following table
presents the placement in the fair value hierarchy and summarizes the changes for the three and six months ended March 31, 2020:
|
|
|
|
|
Fair value measurement at reporting date using
|
|
|
|
|
|
|
Quoted prices in active markets for identical assets
|
|
|
Significant other observable inputs
|
|
|
Significant unobservable inputs
|
|
|
|
Balance
|
|
|
(Level 1)
|
|
|
(Level 2)
|
|
|
(Level 3)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30, 2019:
|
|
$
|
834,000
|
|
|
$
|
–
|
|
|
$
|
–
|
|
|
$
|
834,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payout of deferred cash consideration
|
|
|
(200,000
|
)
|
|
|
|
|
|
|
|
|
|
|
(200,000
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2019:
|
|
|
634,000
|
|
|
|
–
|
|
|
|
–
|
|
|
|
634,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Decrease in fair value of earn-out consideration
|
|
|
(350,000
|
)
|
|
|
|
|
|
|
|
|
|
|
(350,000
|
)
|
Increase in fair value of deferred cash consideration
|
|
|
9,000
|
|
|
|
|
|
|
|
|
|
|
|
9,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2020:
|
|
$
|
293,000
|
|
|
$
|
–
|
|
|
$
|
–
|
|
|
$
|
293,000
|
|
FORWARD INDUSTRIES,
INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 3 FAIR
VALUE MEASUREMENTS (Continued)
The cost method investment
of $326,941 on our condensed consolidated balance sheet as of September 30, 2019 is common stock received from a customer as compensation
for product design services provided by the Company. The shares represent approximately a less than 2% ownership interest in the
customer. Management has determined that the inputs used to value the common stock, at the date of the initial valuation, are
observable, either directly or indirectly, and therefore classified as a Level 2 valuation. Pursuant to ASC 820, the transaction
price of the cash financing round establishes the fair value of the common stock received as consideration unless one of the following
conditions exists:
a.
The transaction is between related parties,
b.
The transaction takes place under duress or the seller is forced to accept the price in the transaction,
c.
The unit of account represented by the transaction price is different from the unit of account for the asset or liability
measured at fair value, or
d.
The market in which the transaction takes place is different from the principal market (or most advantageous market).
On January 21, 2020,
the Company executed a non-negotiable promissory note with the same design segment customer in which we are invested to recover
approximately $1.6 million in accounts receivable which had been reserved as bad debt in fiscal 2019. The principal sum of the
note is approximately $1,626,000. Beginning on April 1, 2020, monthly interest and principal payments, based on a one-year amortization
schedule, were due and payable in arrears on the first day of the month until March 1, 2021. Interest shall accrue at a rate of
8% per annum. To date, we have not received any payments of principal or interest. The note receivable is also reserved and has
a net zero balance on the Company’s condensed consolidated balance sheet.
As a result of default
of the promissory note and the impact of COVID-19, as well as recent performance of the business in which the Company is invested,
including the inability to generate revenue, management has concluded the investment is impaired and has fully reserved for the
investment as of March 31, 2020. The impairment charge of approximately $327,000 is included in the general & administrative
expenses of the condensed consolidated statement of operations and comprehensive loss.
NOTE 4 GOODWILL
The Company has recorded
intangible assets, such as goodwill, trademark, and customer relationships on the IPS reporting unit’s books and accounts
for these in accordance with ASC 350, “Intangibles-Goodwill and Other.” ASC 350 requires an annual test of goodwill
and indefinite-lived assets for impairment, unless circumstances dictate more frequent assessments.
During the three
months ended March 31, 2020, the Company experienced triggering events that resulted in the Company testing its goodwill for impairment.
Those triggering events include the reduction in fair value of the deferred earn-out compensation discussed in Note 3 and revised
revenue and operational projections for the remainder of the fiscal year and future periods. Based on these factors, Management
concluded that it was more likely than not that the fair value has declined below the carrying amount for the IPS reporting unit.
Management then engaged with a valuation firm to calculate the impairment charge by comparing the fair value of a reporting unit
with its carrying amount. With the support of the external valuation firm, management determined the reporting unit’s fair
value to be below the carrying value by $1,015,000 and an impairment charge was recognized for the amount for the period ended
March 31, 2020. Fair value of the reporting unit was determined using Level 3 inputs, which is a combination of asset-based, income
and market approaches. These estimates and assumptions include discount rate, terminal growth rate, selection of peer group companies
and control premium applied as well as forecasts of revenue growth rates, gross margins, operating margins, and working capital
requirements. Any changes in the judgments, estimates, or assumptions used could produce significantly different results.
FORWARD INDUSTRIES,
INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 4 GOODWILL (Continued)
Below is the rollforward
of goodwill for IPS, the only reporting unit with goodwill.
|
|
IPS
|
|
|
Consolidated
|
|
|
|
|
|
|
|
|
September 30, 2019:
|
|
$
|
2,182,427
|
|
|
$
|
2,182,427
|
|
|
|
|
|
|
|
|
|
|
Goodwill impairment
|
|
|
(1,015,000
|
)
|
|
|
(1,015,000
|
)
|
|
|
|
|
|
|
|
|
|
March 31, 2020:
|
|
$
|
1,167,427
|
|
|
$
|
1,167,427
|
|
NOTE 5 SEGMENT INFORMATION
The Company, post
IPS acquisition, conducts its business through two operating segments, which are also its reportable segments:
• Distribution
and
• Design
Segment operating
loss reflects results before shared corporate and unallocated administrative expenses and income taxes. Shared corporate and unallocated
administrative expenses principally consist of costs for corporate and administrative support functions.
|
|
For the Three Months Ended
March 31,
|
|
|
For the Six Months Ended
March 31,
|
|
|
|
2020
|
|
|
2019
|
|
|
2020
|
|
|
2019
|
|
Revenue
|
|
|
|
|
|
|
|
|
|
|
|
|
Distribution
|
|
$
|
4,623,895
|
|
|
$
|
4,769,558
|
|
|
$
|
9,320,138
|
|
|
$
|
11,050,284
|
|
Design
|
|
|
3,307,482
|
|
|
|
3,402,909
|
|
|
|
7,004,093
|
|
|
|
7,305,466
|
|
Total Revenue
|
|
|
7,931,377
|
|
|
|
8,172,467
|
|
|
|
16,324,231
|
|
|
|
18,355,750
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of Sales
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Distribution
|
|
|
4,062,864
|
|
|
|
4,017,886
|
|
|
|
8,156,182
|
|
|
|
9,312,318
|
|
Design
|
|
|
2,415,364
|
|
|
|
2,843,736
|
|
|
|
4,994,891
|
|
|
|
6,429,546
|
|
Total Cost of Sales
|
|
|
6,478,228
|
|
|
|
6,861,622
|
|
|
|
13,151,073
|
|
|
|
15,741,864
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment Operating Income (loss) from operations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Distribution
|
|
|
(378,012
|
)
|
|
|
(616,784
|
)
|
|
|
(821,201
|
)
|
|
|
(610,787
|
)
|
Design
|
|
|
(1,288,685
|
)
|
|
|
(458,277
|
)
|
|
|
(874,625
|
)
|
|
|
(944,801
|
)
|
Total Income (loss) from operations
|
|
|
(1,666,697
|
)
|
|
|
(1,075,061
|
)
|
|
|
(1,695,826
|
)
|
|
|
(1,555,588
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Distribution
|
|
|
307,262
|
|
|
|
(34,794
|
)
|
|
|
273,682
|
|
|
|
(71,758
|
)
|
Design
|
|
|
(12,179
|
)
|
|
|
(21,050
|
)
|
|
|
(31,127
|
)
|
|
|
(34,086
|
)
|
Total Other expenses
|
|
|
295,083
|
|
|
|
(55,844
|
)
|
|
|
242,555
|
|
|
|
(105,844
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before income taxes
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Distribution
|
|
|
(70,750
|
)
|
|
|
(651,578
|
)
|
|
|
(547,519
|
)
|
|
|
(682,545
|
)
|
Design
|
|
|
(1,300,864
|
)
|
|
|
(479,327
|
)
|
|
|
(905,752
|
)
|
|
|
(978,887
|
)
|
Total Income (loss) before income taxes
|
|
$
|
(1,371,614
|
)
|
|
$
|
(1,130,905
|
)
|
|
$
|
(1,453,271
|
)
|
|
$
|
(1,661,432
|
)
|
FORWARD INDUSTRIES,
INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 5 SEGMENT
INFORMATION (Continued)
The following table
presents total assets by operating segment:
|
|
March 31,
|
|
|
September 30,
|
|
|
|
2020
|
|
|
2019
|
|
|
|
|
|
|
|
|
Distribution
|
|
$
|
7,227,850
|
|
|
$
|
9,554,465
|
|
Design
|
|
|
8,956,976
|
|
|
|
6,539,887
|
|
Total assets
|
|
$
|
16,184,826
|
|
|
$
|
16,094,352
|
|
NOTE 6 SHARE-BASED
COMPENSATION
Stock Options
On
February 11, 2020, the Company granted five-year options to directors to purchase an aggregate of 248,019 shares of common stock
at an exercise price of $1.13 per share. The shares vest one year from the grant date. The options had an aggregate grant date
fair value of $144,999, which is being amortized over the vesting period of the options.
The
options granted during the period ended March 31, 2020 had a weighted average grant date value of $0.58 per share.
On
February 5, 2019, the Company granted five-year options to three non-employee directors to purchase an aggregate of 150,021 shares
of common stock at an exercise price of $1.54 per share. The shares vested one year from the grant date. The options had an aggregate
grant date fair value of $120,000, which was amortized over the vesting period of the options.
On
February 5, 2019, the Company granted five-year immediately vesting options to two non-employee directors to purchase an aggregate
of 140,460 shares of common stock at an exercise price of $1.54 per share. The options had an aggregate grant date fair value
of $107,800, which was recognized immediately.
The
options granted during the period ended March 31, 2019 had a weighted average grant date value of $0.78 per share.
The fair value of
each option award is estimated on the date of grant using the Black-Scholes option pricing model that uses the following assumptions.
The expected term represents the period over which the stock option awards are expected to be outstanding. The Company utilizes
the “simplified” method to develop an estimate of the expected term of “plain vanilla” employee option
grants. The expected volatility used is based on the historical price of the Company’s stock over the most recent period
commensurate with the expected term of the award. The risk-free interest rate used is based on the implied yield of U.S. Treasury
zero-coupon issues with a remaining term equivalent to the award’s expected term. The Company historically has not paid any
dividends on its common stock and had no intention to do so on the date the share-based awards were granted. The estimated annual
forfeiture rate is based on management’s expectations and will reduce expense ratably over the vesting period. The forfeiture
rate will be adjusted periodically based on the extent to which actual option forfeitures differ, or are expected to differ, from
the previous estimate, when it is material.
FORWARD INDUSTRIES,
INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 6 SHARE-BASED COMPENSATION (Continued)
In
applying the Black-Scholes option pricing model to options granted, the Company used the following assumptions:
|
|
For
the Three Months Ended
March 31,
|
|
For the Six Months
Ended
March 31,
|
|
|
2020
|
|
2020
|
|
2019
|
|
2020
|
Expected term (years)
|
|
3.00
|
|
2.50-2.75
|
|
3.00
|
|
2.50-2.75
|
Expected volatility
|
|
79.0%
|
|
82.0%
|
|
79.0%
|
|
82.0%
|
Risk-free interest rate
|
|
1.39%
|
|
2.53%
|
|
1.39%
|
|
2.53%
|
Expected dividends
|
|
0.00%
|
|
0.00%
|
|
0.00%
|
|
0.00%
|
Estimated annual forfeiture rate
|
|
0%
|
|
0%
|
|
0%
|
|
0%
|
The
following table summarizes stock option activity during the six months ended March 31, 2020:
|
|
|
|
|
|
|
|
Weighted
|
|
|
|
|
|
|
|
|
|
Weighted
|
|
|
Average
|
|
|
|
|
|
|
|
|
|
Average
|
|
|
Remaining
|
|
|
|
|
|
|
Number of
|
|
|
Exercise
|
|
|
Life
|
|
|
Intrinsic
|
|
|
|
Options
|
|
|
Price
|
|
|
In Years
|
|
|
Value
|
|
Outstanding, September 30, 2019
|
|
|
812,879
|
|
|
$
|
1.69
|
|
|
|
|
|
|
|
|
|
Granted
|
|
|
248,019
|
|
|
|
1.13
|
|
|
|
|
|
|
|
|
|
Exercised
|
|
|
–
|
|
|
|
–
|
|
|
|
|
|
|
|
|
|
Forfeited
|
|
|
(56,501
|
)
|
|
|
2.41
|
|
|
|
|
|
|
|
|
|
Expired
|
|
|
–
|
|
|
|
–
|
|
|
|
|
|
|
|
|
|
Outstanding, March 31, 2020
|
|
|
1,004,397
|
|
|
$
|
1.51
|
|
|
|
3.9
|
|
|
$
|
26,800
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable, March 31, 2020
|
|
|
736,688
|
|
|
$
|
1.64
|
|
|
|
3.6
|
|
|
$
|
26,800
|
|
The following table
provides additional information regarding stock option awards that were outstanding and exercisable at March 31, 2020:
Options Outstanding
|
|
Options Exercisable
|
|
Exercise
Price
|
|
Weighted
Average
Exercise
Price
|
|
|
Outstanding
Number of
Options
|
|
|
Weighted
Average Exercise
Price
|
|
|
Weighted
Average
Remaining
Life In
Years
|
|
|
Exercisable
Number of
Options
|
|
$0.64 to $1.23
|
|
$
|
1.05
|
|
|
|
325,519
|
|
|
$
|
0.80
|
|
|
|
4.6
|
|
|
|
77,500
|
|
$1.44 to $1.67
|
|
|
1.51
|
|
|
|
605,378
|
|
|
|
1.49
|
|
|
|
3.8
|
|
|
|
585,688
|
|
$2.73 to $2.73
|
|
|
2.73
|
|
|
|
11,000
|
|
|
|
2.48
|
|
|
|
1.4
|
|
|
|
11,000
|
|
$3.73 to $3.79
|
|
|
3.74
|
|
|
|
62,500
|
|
|
|
3.74
|
|
|
|
0.9
|
|
|
|
62,500
|
|
|
|
|
|
|
|
|
1,004,397
|
|
|
|
|
|
|
|
3.6
|
|
|
|
736,688
|
|
The
Company recognized compensation expense of approximately $36,000 and $135,000 during the three months ended March 31, 2020 and
2019, respectively, and approximately $69,000 and $145,000 during the six months ended March 31, 2020 and 2019, respectively, for
stock option awards in its condensed consolidated statements of operations and comprehensive loss.
FORWARD INDUSTRIES,
INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 6 SHARE-BASED COMPENSATION (Continued)
As
of March 31, 2020, there was approximately $133,000 of total unrecognized compensation cost related to nonvested stock option awards
that is expected to be recognized over a weighted average period of 0.9 years.
Restricted Stock Awards
The
Company recognized compensation expense of approximately $0 and $1,000 during the three months ended March 31, 2020 and 2019, respectively,
and approximately $0 and $3,000 during the six months ended March 31, 2020 and 2019, respectively, for restricted stock awards
in its condensed consolidated statements of operations and comprehensive loss. As of March 31, 2020, there was no unrecognized
compensation expense related to nonvested restricted stock awards.
NOTE 7 LOSS
PER SHARE
Basic loss per share
data for each period presented is computed using the weighted average number of shares of common stock outstanding during each
such period. Diluted loss per share data is computed using the weighted average number of common and dilutive common equivalent
shares outstanding during each period. Dilutive common-equivalent shares consist of shares that would be issued upon the exercise
of stock options and warrants, computed using the treasury stock method.
|
|
For the Three Months Ended
|
|
|
For the Six Months Ended
|
|
|
|
March 31,
|
|
|
March 31,
|
|
|
|
2020
|
|
|
2019
|
|
|
2020
|
|
|
2019
|
|
Numerator:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
$
|
(1,371,614
|
)
|
|
$
|
(1,130,905
|
)
|
|
$
|
(1,453,271
|
)
|
|
$
|
(1,661,432
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Denominator:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding - basic
|
|
|
9,533,851
|
|
|
|
9,532,645
|
|
|
|
9,533,851
|
|
|
|
9,530,207
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effects of dilutive securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assumed exercise of stock options, treasury stock method
|
|
|
–
|
|
|
|
–
|
|
|
|
–
|
|
|
|
–
|
|
Assumed vesting of restricted stock, treasury stock method
|
|
|
–
|
|
|
|
–
|
|
|
|
–
|
|
|
|
–
|
|
Weighted average dilutive potential common shares
|
|
|
–
|
|
|
|
–
|
|
|
|
–
|
|
|
|
–
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding - diluted
|
|
|
9,533,851
|
|
|
|
9,532,645
|
|
|
|
9,533,851
|
|
|
|
9,530,207
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic loss per share
|
|
$
|
(0.14
|
)
|
|
$
|
(0.12
|
)
|
|
$
|
(0.15
|
)
|
|
$
|
(0.17
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted loss per share
|
|
$
|
(0.14
|
)
|
|
$
|
(0.12
|
)
|
|
$
|
(0.15
|
)
|
|
$
|
(0.17
|
)
|
The following securities
were excluded from the calculation of diluted earnings per share because their inclusion would have been anti-dilutive:
|
|
As of March 31,
|
|
|
|
2020
|
|
|
2019
|
|
Options
|
|
|
1,004,397
|
|
|
|
815,547
|
|
Warrants
|
|
|
151,335
|
|
|
|
151,335
|
|
Total potentially dilutive shares
|
|
|
1,155,732
|
|
|
|
966,882
|
|
FORWARD INDUSTRIES,
INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 8 CONCENTRATIONS
Concentration of
Revenues and Accounts Receivable
For the three and
six months ended March 31, 2020 and 2019, the Company had significant customers with individual percentage of total revenues equaling
10% or greater. The risk of collecting on Accounts Receivable for all customers is enhanced as a result of the economic impact
of the COVID-19 pandemic. The concentrations of revenues and accounts receivable for each reporting segment are as follows:
Distribution Segment Revenues Concentration
|
|
For the Three Months Ended
|
|
|
For the Six Months Ended
|
|
|
|
March 31,
|
|
|
March 31,
|
|
|
|
2020
|
|
|
2019
|
|
|
2020
|
|
|
2019
|
|
Customer 1
|
|
|
15.9%
|
|
|
|
29.9%
|
|
|
|
23.6%
|
|
|
|
28.7%
|
|
Customer 2
|
|
|
37.0%
|
|
|
|
28.7%
|
|
|
|
35.6%
|
|
|
|
30.0%
|
|
Customer 3
|
|
|
20.5%
|
|
|
|
15.3%
|
|
|
|
16.9%
|
|
|
|
14.6%
|
|
Customer 4
|
|
|
11.6%
|
|
|
|
11.1%
|
|
|
|
8.3%
|
|
|
|
10.3%
|
|
Totals
|
|
|
85.0%
|
|
|
|
85.0%
|
|
|
|
84.4%
|
|
|
|
83.6%
|
|
Design Segment Revenues Concentration
|
|
For the Three Months Ended
|
|
|
For the Six Months Ended
|
|
|
|
March 31,
|
|
|
March 31,
|
|
|
|
2020
|
|
|
2019
|
|
|
2020
|
|
|
2019
|
|
Customer 1
|
|
|
13.6%
|
|
|
|
23.2%
|
|
|
|
18.4%
|
|
|
|
18.6%
|
|
Customer 2
|
|
|
16.3%
|
|
|
|
7.9%
|
|
|
|
12.8%
|
|
|
|
10.5%
|
|
Customer 3
|
|
|
–
|
|
|
|
1.4%
|
|
|
|
–
|
|
|
|
11.4%
|
|
Customer 4
|
|
|
21.1%
|
|
|
|
–
|
|
|
|
15.4%
|
|
|
|
–
|
|
Customer 5
|
|
|
8.6%
|
|
|
|
5.1%
|
|
|
|
10.6%
|
|
|
|
4.0%
|
|
Totals
|
|
|
59.6%
|
|
|
|
37.6%
|
|
|
|
57.2%
|
|
|
|
44.5%
|
|
At March 31, 2020
and September 30, 2019, concentrations of accounts receivable with significant customers representing 10% or greater of segment
accounts receivable were as follows:
Distribution Segment Accounts Receivable
Concentration
|
|
March 31,
2020
|
|
|
September 30,
2019
|
|
Customer 1
|
|
|
21.8%
|
|
|
|
21.2%
|
|
Customer 2
|
|
|
28.7%
|
|
|
|
29.0%
|
|
Customer 3
|
|
|
23.2%
|
|
|
|
23.6%
|
|
Customer 4
|
|
|
12.6%
|
|
|
|
15.7%
|
|
Totals
|
|
|
86.3%
|
|
|
|
89.5%
|
|
FORWARD INDUSTRIES,
INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 8 CONCENTRATIONS (Continued)
Design Segment Accounts Receivable
Concentration
|
|
March 31,
2020
|
|
|
September 30,
2019
|
|
Customer 1
|
|
|
9.7%
|
|
|
|
33.7%
|
|
Customer 2
|
|
|
36.1%
|
|
|
|
5.9%
|
|
Customer 3
|
|
|
14.2%
|
|
|
|
8.8%
|
|
Totals
|
|
|
60.0%
|
|
|
|
48.4%
|
|
NOTE 9 RELATED
PARTY TRANSACTIONS
Buying Agency and
Supply Agreement
On March 12, 2012,
the Company entered into a Buying Agency and Supply Agreement (the “Supply Agreement”) with Forward Industries Asia-Pacific
Corporation, a British Virgin Islands corporation (“Forward China”). The Supply Agreement, as amended, provides that,
upon the terms and subject to the conditions set forth therein, Forward China will act as the Company’s exclusive buying
agent and supplier of Products (as defined in the Supply Agreement) in the Asia-Pacific region. The Company purchases
products at Forward China’s cost and also pays to Forward China a monthly service fee equal to the sum of: (i) $100,000;
and (ii) 4% of “Adjusted Gross Profit”, which is defined as the selling price less the cost from Forward China. The
amended Supply Agreement was scheduled to expire on March 8, 2019, subject to renewal. Terence Bernard Wise, Chief Executive Officer
and Chairman of the Company, is the owner of Forward China. In addition, Jenny P. Yu, a Managing Director of Forward China, beneficially
owns more than 5% of the Company’s shares of common stock. The Company recognized approximately $339,000 and $344,000 during
the three months ended March 31, 2020 and 2019, respectively, and approximately $676,000 and $703,000 during the six months ended
March 31, 2020 and 2019, respectively, in service fees paid to Forward China, which are included as a component of cost of goods
sold in the accompanying condensed consolidated statements of operations and comprehensive loss. Effective October 22, 2019, the
Company extended the term of the supply agreement to October 22, 2020 under the same terms, substantially.
Promissory Note
On January 18, 2018,
the Company issued a $1.6 million promissory note payable to Forward China in order to fund the acquisition of IPS. The promissory
note bears an interest rate of 8% per annum. Monthly interest payments commenced on February 18, 2018. The original maturity date
was January 18, 2019 and has been extended to July 17, 2020. The maturity date of the note has been extended on several occasions
to assist the Company with liquidity. For the three and six months ended March 31, 2020 and 2019, the Company made approximately
$32,000 and $64,000, respectively, in interest payments associated with the note. The $1.6 million note payable is included as
a component of the notes payable - short-term portion line of the accompanying condensed consolidated balance sheets.
Related Party Sales
The Company’s
design division provided services to a customer whose Chief Operating and Financial Officer and equity owner is an immediate family
member of a director on the Company’s board and a member on the Board’s Audit and Compensation committees. The Company
sold approximately $6,000 and $58,000 in design services to the customer for the three months ended March 31, 2020 and 2019, respectively,
and $44,000 and $58,000 for the six months ended March 31, 2020 and 2019, respectively. At March 31, 2020 and September 30, 2019,
there were outstanding receivables of approximately $0 and $9,000, respectively, from the customer.
FORWARD INDUSTRIES,
INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 10 LEGAL
PROCEEDINGS
From time to time,
the Company may become a party to legal actions or proceedings in the ordinary course of its business. As of March 31, 2020, there
were no such actions or proceedings, either individually or in the aggregate, that, if decided adversely to the Company’s
interests, the Company believes would be material to its business.
NOTE 11 LINE
OF CREDIT
The Company, specifically
IPS, has a $1,300,000 revolving line of credit with TD Bank which was renewed at the discretion of the lender on April 30, 2019.
The maturity date has been extended by the lender to August 29, 2020. The line of credit was amended and modified on September
28, 2018 to extend the line of credit limit from $1,000,000 to $1,300,000 and repayment was guaranteed by the Company and is secured
by all of IPS’ assets. The interest rate on the line of credit is 0.75% above The Wall Street Journal prime rate.
The effective interest rate at March 31, 2020 and September 30, 2019 was 4.0% and 5.75%, respectively. As of March 31, 2020, the
Company had $900,000 available under the line of credit. The Company is subject to certain debt-service ratio requirements which
are measured annually. With a net loss for the six months ended March 31, 2020 of approximately $875,000 for IPS, there is a likely
risk of failing covenant testing at year end. As such, the lender may demand payment in full upon default. As of September 30,
2019, the Company was in violation of the required debt-service ratio covenants. The Company was granted a waiver of the violation
from the lender.
NOTE 12 DEBT
On April 1, 2016,
IPS entered into a term loan with a lender in the amount of $325,000. The loan matures on April 1, 2020 and bears interest at a
rate of 4.215% per annum. Interest and principal of $7,378 is paid on a monthly basis through maturity. This loan is secured by
all of the IPS’ assets and is guaranteed by the Company. Outstanding balance as of March 31, 2020 and September 30, 2019
was approximately $7,000 and $52,000, respectively. The loan was paid off in early April 2020 per the agreement. The agreement
contains certain restrictive covenants measured annually. As of September 30, 2019, the Company was in violation of the required
debt-service ratio covenants. The Company was granted a waiver of the violation from the lender.
On December 11, 2017,
IPS entered into an installment payment financing arrangement with a lender in the amount of approximately $23,000. IPS makes monthly
payments of $1,035, which includes an implied interest rate of 9.5%, for 24 months. The last payment was made in December 2019.
The loan balance was $0 and approximately $3,000 at March 31, 2020 and September 30, 2019, respectively.
NOTE 13 MOONI
AGREEMENT
On January 29, 2019,
the Company entered into a three-year Distribution Agreement (the “Agreement”) with Mooni International AB (“Mooni”)
and its owner, Staffan Bern (the “Owner”). In accordance with the Agreement, the Company: (i) was appointed as the
exclusive distributor of Mooni's current and future products (including future products developed or offered by Mooni and/or the
Owner) in North America, (ii) subject to certain repayment requirements, paid $400,000 to Mooni, and (iii) was granted an option
to purchase a controlling interest of Mooni at a valuation not to exceed $5 million which, if exercised, would be effective on
the 12-month anniversary of the effective date of the Agreement. This option was not exercised. Additionally, Forward China, a
company owned by Terence Wise, the Company's Chairman and Chief Executive Officer, was named the designated supplier under the
Agreement. As of March 31, 2020, the unamortized fee of approximately $244,000 is included in prepaid expenses and other current
assets and other assets for the short-term and long-term components, respectively, in the accompanying condensed consolidated
balance sheets. Amortization of the cost for the three and six months ended March 31, 2020 of approximately $33,000 and $67,000,
respectively, is included in the Sales and Marketing expenses in the accompanying condensed consolidated statement of operations
and comprehensive loss.
FORWARD INDUSTRIES,
INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 14 LEASES
Operating Leases
The Company leases
office space for its corporate headquarters in West Palm Beach, Florida under a 90-month agreement expiring in September 2020.
The operating lease granted six initial months of free rent and escalates at 3% per year. The monthly rent payment is approximately
$7,700, which includes common area maintenance costs.
The Company leases
office space for its Distribution segment sales and administrative office in Cham, Switzerland on a month-to-month basis. The monthly
rent payment is $1,599 CHF, which is approximately $1,615.
IPS leases office
space in Hauppauge, New York under a non-cancelable lease agreement expiring in February 2027. The monthly rent payment is approximately
$29,000, which includes power utilities.
IPS leases office
space in Ronkonkoma, New York under a three-year agreement expiring in January 2022. The monthly rent payment is $4,400.
As of March 31, 2020,
the Company did not have additional operating and financing leases that have not yet commenced.
Total operating lease expense for the
three months ended March 31, 2020 and 2019 was approximately $122,000 and $134,000, respectively, and is recorded in general and
administrative expenses on the condensed consolidated statements of operations and comprehensive loss. Total operating lease expense
for the six months ended March 31, 2020 and 2019 were approximately $255,000 and $249,000, respectively, and are recorded in general
and administrative expenses on the condensed consolidated statements of operations and comprehensive loss.
Supplemental cash
flows information related to leases was as follows:
|
|
Six Months Ended March 31, 2020
|
|
|
Weighted Average Remaining Lease Term
|
|
|
|
|
|
Operating leases
|
|
|
11.51
|
|
Years
|
Finance leases
|
|
|
1.08
|
|
Years
|
|
|
|
|
|
|
Weighted Average Discount Rate
|
|
|
|
|
|
Operating leases
|
|
|
5.75%
|
|
|
Finance leases
|
|
|
5.75%
|
|
|
Future minimum payments
under non-cancellable operating leases as of March 31, 2020 were as follows:
For the Years Ending September 30,
|
|
Amount
|
|
2020
|
|
$
|
249,400
|
|
2021
|
|
|
413,332
|
|
2022
|
|
|
380,389
|
|
2023
|
|
|
375,732
|
|
2024
|
|
|
385,640
|
|
Thereafter
|
|
|
3,200,193
|
|
Total future minimum lease payments
|
|
$
|
5,004,686
|
|
|
|
|
|
|
Less: amount representing imputed interest
|
|
|
(1,415,047
|
)
|
|
|
|
|
|
Total
|
|
|
3,589,639
|
|
FORWARD INDUSTRIES,
INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 14 LEASES (Continued)
Finance Leases
The Company, specifically
IPS, leases computer equipment through various finance lease agreements expiring through January 2022. Amortization expense related
to assets under finance leases were $10,982 and $22,989 during the three and six months ended March 31, 2020, respectively. Interest
expense related to assets under finance leases were $828 and $1,856 during the three and six months ended March 31, 2020, respectively.
Future minimum payments under non-cancellable
operating leases as of March 31, 2020 were as follows:
For the Years Ending September 30,
|
|
Amount
|
|
2020
|
|
$
|
25,315
|
|
2021
|
|
|
22,990
|
|
2022
|
|
|
5,632
|
|
Total future minimum lease payments
|
|
|
53,937
|
|
|
|
|
|
|
Less: amount representing imputed interest
|
|
|
(3,956
|
)
|
|
|
|
|
|
Total
|
|
|
49,981
|
|
NOTE 15 SUBSEQUENT
EVENTS
On April 18, 2020,
the Company entered into a loan with TD Bank, N.A. in an aggregate principal amount of approximately $1.4 million under the Paycheck
Protection Program (the “PPP Loan”) pursuant to the recently enacted U.S. Coronavirus Aid, Relief, and Economic Security
Act (the “CARES Act”). The loan matures two years from the date of the note on April 18, 2022 and bears an interest
rate of 1.00% per annum. The Company must pay monthly principal and interest payments on the outstanding principal balance of
the PPP Loan amortized over the term of the loan beginning seven months from the month this Note is dated until the Maturity Date
when the entire principal balance remaining unpaid, along with all accrued and unpaid interest, shall be due and payable in full.
This loan is unsecured, and the Company may apply for forgiveness of the loan in accordance with the terms of the CARES Act. Subsequent
to receiving the loan, the Company amended the loan application to address certain inconsistencies. The application is subject
to review by the Small Business Administration.
The Company
has entered into a non-binding letter of intent to acquire all of the assets of a design-development company focused on products
in the medical industry, for consideration of cash, assumption of liabilities and stock in the aggregate of up to approximately
$1.5 million. The Company can provide no assurance that the transaction will close and, if so, it will close on the terms
disclosed herein.
|
ITEM 2.
|
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
The following discussion
and analysis should be read in conjunction with our unaudited condensed consolidated financial statements, and the notes thereto,
and other financial information appearing elsewhere in this Quarterly Report on Form 10-Q and the audited consolidated financial
statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended September 30, 2019. The
following discussion and analysis compares our consolidated results of operations for the three and six months ended March 31,
2020 (the “2020 Quarter” and “2020 Period”, respectively) with those for the three and six months ended
March 31, 2019 (the “2019 Quarter” and “2019 Period”, respectively). All figures in the following
discussion are presented on a consolidated basis. All dollar amounts and percentages presented herein have been rounded to approximate
values.
Business Overview
Forward Industries,
Inc. designs and distributes carry and protective solutions, primarily for hand held electronic devices. The Company’s principal
customer market is original equipment manufacturers, or “OEMs” (or the contract manufacturing firms of these distribution
customers), that either package our products as accessories “in box” together with their branded product offerings,
or sell them through their retail distribution channels. The Company’s distribution products include carrying cases and other
accessories for medical monitoring and diagnostic kits and a variety of other portable electronic and non-electronic products (such
as sporting and recreational products, bar code scanners, smartphones, GPS location devices, tablets, firearms). The Company’s
distribution customers are located in (i) the Asia-Pacific Region, which we refer to as the “APAC Region”; (ii) Europe,
the Middle East, and Africa, which we refer to as the “EMEA Region”; and (iii) the Americas. The Company does not manufacture
any of its distribution products and sources substantially all of its distribution products from independent suppliers in China,
through Forward China.
As a result of
the expansion of the design development capabilities through its wholly owned subsidiary, IPS, the Company has begun
introducing proprietary products to the market from concepts brought to it from a number of different sources. The Company
provides clients, both big and small, a true, authentic "one-stop shop" for product design, development,
distribution and manufacturing solutions.
On January 29, 2019,
the Company entered into a distribution agreement with Mooni AB International. By virtue of our strategic collaboration and distribution
agreement with Mooni AB International, we have secured a portfolio of smart enabled products which we anticipate will be distributed
to retail outlets in the United States. As a result of this collaboration and other product initiatives, the Company began to invest
in and build out a distribution network for retail. The distribution network will be responsible for getting products into big
box retailers for retail consumption. This build out is a continuation of our strategy to be a one-stop shop for product development,
manufacture and distribution and represents a significant achievement in completing the strategic process of taking a product from
concept to the consumer. We have built out a sales team that covers North America by leveraging the manufacturer's representative
model. We have identified and signed agreements with long standing firms that have years of experience and relationships with the
big box retailers that we are targeting in both United States and Canada.
Through the manufacture
representative agreements we currently have in place, we hope to gain sales coverage to retailers such as Best Buy, Target, Walmart,
Costco, CVS, Walgreens, Staples, Office Depot and many others. The manufacture representative model allows us to engage and support
a large sales team and cover a lot of territory with a variable cost model as these representatives work on commission only.
In December 2019,
a novel strain of coronavirus known as COVID-19 was reported to have surfaced in China, and by March 2020 the spread of the virus
had resulted in a world-wide pandemic. The U.S. economy has been largely shut down by mass quarantines and government mandated
stay-in-place orders (the “Orders”) to halt the spread of the virus. These Orders have required substantially all of
our employees to work from home.
In certain jurisdictions,
the Orders are beginning to be relaxed, but considerable uncertainty remains about the ultimate impact on our business. Even if
the Orders are lifted, there is no assurance that they will not be reinstated if the spread of COVID-19 resumes. While the current
business disruption is expected to be temporary, the long-term financial impact on our business cannot be reasonably estimated
at this time.
Variability of Revenues
and Results of Operations
Because a high percentage
of our net revenues is highly concentrated in a few large customers, and because the volumes of these customers’ order flows
to us are highly variable, with short lead times, our quarterly revenues, and consequently our results of operations, are susceptible
to significant variability over a relatively short period of time. Since the acquisition of IPS, the variability has diminished
to a certain extent.
Critical Accounting
Policies and Estimates
We discuss the material
accounting policies that are critical in making the estimates and judgments in our Annual Report on Form 10-K for the fiscal year
ended September 30, 2019, under the caption “Management’s Discussion and Analysis—Critical Accounting Policies
and Estimates”. There has been no material change in critical accounting policies or estimates during the period covered
by this report.
Recent Accounting Pronouncements
For information on
recent accounting pronouncements and impacts, see Note 2 to the unaudited condensed consolidated financial statements.
RESULTS OF OPERATIONS
FOR THE THREE MONTHS ENDED MARCH 31, 2020 COMPARED TO THE THREE MONTHS ENDED MARCH 31, 2019
The results of operations
disclosed below presents Forward’s distribution business and IPS’ design segments as distinct operating units. Management
continues to expand our retail efforts for the distribution segment in an attempt to improve profitability. Management believes
the profitability for the design segment will continue to improve as the Company streamlines operating expenses.
Net Income (Loss)
Distribution Segment
Distribution segment
net loss was approximately $(71,000) in the 2020 Quarter compared to net loss of approximately $(651,000) in the 2019 Quarter.
Net loss in the 2020 Quarter was primarily due to a decline in sales and gross profit offset by a fair value adjustment to the
earn-out and deferred cash components of the deferred compensation as discussed in Note 3 of $341,000, as reflected in the table
below.
Design Segment
Design segment net
loss was approximately $(1,301,000) in the 2020 Quarter compared to a net loss of approximately $(480,000) in the 2019 Quarter.
Net loss in the 2020 Quarter was primarily due to the goodwill impairment loss of $(1,015,000) discussed in Note 4 of the Notes
to the Condensed Consolidated Statements of Operations, and, to a lesser extent, a reduction in revenue and an increase in operating
expenses in addition to a write-down of an investment as discussed in Note 3 of approximately $327,000.
|
|
Main Components
of Net Loss
|
|
|
|
(amounts in thousands)
|
|
|
|
2020
Quarter
|
|
|
2019
Quarter
|
|
|
Increase
Decrease
|
|
|
|
Consolidated
|
|
|
Distribution
|
|
|
Design
|
|
|
Consolidated
|
|
|
Distribution
|
|
|
Design
|
|
|
Consolidated
|
|
Net
revenues
|
|
$
|
7,931
|
|
|
$
|
4,624
|
|
|
$
|
3,307
|
|
|
$
|
8,173
|
|
|
$
|
4,770
|
|
|
$
|
3,403
|
|
|
$
|
(242
|
)
|
Gross profit
|
|
$
|
1,453
|
|
|
$
|
561
|
|
|
$
|
892
|
|
|
$
|
1,311
|
|
|
$
|
752
|
|
|
$
|
559
|
|
|
$
|
142
|
|
Less:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales and marketing expenses
|
|
|
480
|
|
|
|
351
|
|
|
|
129
|
|
|
|
428
|
|
|
|
315
|
|
|
|
113
|
|
|
|
52
|
|
General and administrative
expenses
|
|
|
1,625
|
|
|
|
588
|
|
|
|
1,037
|
|
|
|
1,958
|
|
|
|
1,053
|
|
|
|
905
|
|
|
|
(333
|
)
|
Goodwill
impairment
|
|
|
1,015
|
|
|
|
–
|
|
|
|
1,015
|
|
|
|
–
|
|
|
|
–
|
|
|
|
–
|
|
|
|
1,015
|
|
Operating loss
|
|
|
(1,667
|
)
|
|
|
(378
|
)
|
|
|
(1,289
|
)
|
|
|
(1,075
|
)
|
|
|
(616
|
)
|
|
|
(459
|
)
|
|
|
(592
|
)
|
Other
income (expenses)
|
|
|
295
|
|
|
|
307
|
|
|
|
(12
|
)
|
|
|
(56
|
)
|
|
|
(35
|
)
|
|
|
(21
|
)
|
|
|
351
|
|
Net loss
|
|
$
|
(1,372
|
)
|
|
$
|
(71
|
)
|
|
$
|
(1,301
|
)
|
|
$
|
(1,131
|
)
|
|
$
|
(651
|
)
|
|
$
|
(480
|
)
|
|
$
|
(241
|
)
|
Basic and diluted loss per share was $(0.14)
per share for the 2020 Quarter and $(0.12) per share for the 2019 Quarter.
Net Revenues
Distribution Segment
Net revenues in the
distribution segment declined approximately $0.15 million, or 3%, to $4.62 million in the 2020 Quarter from $4.77 million in the
2019 Quarter as a result of a reduction in Diabetic product line revenue slightly offset by a marginal increase in Other Product
revenue. The following tables set forth revenues by channel, product line and geographic location of our Distribution segment customers
for the periods indicated:
|
|
Net Revenues for 2020 Quarter
|
|
|
|
(amounts in thousands)
|
|
|
|
EMEA
|
|
|
APAC
|
|
|
Americas
|
|
|
Total
|
|
Diabetic products
|
|
$
|
1,904
|
|
|
$
|
842
|
|
|
$
|
1,342
|
|
|
$
|
4,088
|
|
Other products
|
|
|
33
|
|
|
|
166
|
|
|
|
337
|
|
|
|
536
|
|
Total net revenues
|
|
$
|
1,937
|
|
|
$
|
1,008
|
|
|
$
|
1,679
|
|
|
$
|
4,624
|
|
|
|
Net Revenues for 2019 Quarter
|
|
|
|
(amounts in thousands)
|
|
|
|
EMEA
|
|
|
APAC
|
|
|
Americas
|
|
|
Total
|
|
Diabetic products
|
|
$
|
1,717
|
|
|
$
|
1,395
|
|
|
$
|
1,153
|
|
|
$
|
4,265
|
|
Other products
|
|
|
71
|
|
|
|
277
|
|
|
|
157
|
|
|
|
505
|
|
Total net revenues
|
|
$
|
1,788
|
|
|
$
|
1,672
|
|
|
$
|
1,310
|
|
|
$
|
4,770
|
|
Diabetic Product Revenues
Forward’s distribution
segment manufactures to the order of, and sells carrying cases for blood glucose diagnostic kits directly to OEMs (or their contract
manufacturers). The OEM customer or its contract manufacturer packages our carry cases “in box” as a custom accessory
for the OEM’s blood glucose testing and monitoring kits, or to a lesser extent, sells them through their retail distribution
channels.
Revenues from Diabetic
Products declined approximately $0.2 million, or 4%, to approximately $4.1 million in the 2020 Quarter from approximately $4.2
million in the 2019 Quarter. This decline was due to combination of reduced demand and pricing pressures from most of our major
Diabetic Products customers.
The following table
sets forth our distribution segment net revenues by Diabetic Products customer for the periods indicated:
|
|
(amounts in thousands)
|
|
|
|
2020
Quarter
|
|
|
2019
Quarter
|
|
|
Increase (Decrease)
|
|
Diabetic Products Customer A
|
|
$
|
735
|
|
|
$
|
1,424
|
|
|
$
|
(689
|
)
|
Diabetic Products Customer B
|
|
|
1,709
|
|
|
|
1,367
|
|
|
|
342
|
|
Diabetic Products Customer C
|
|
|
948
|
|
|
|
802
|
|
|
|
146
|
|
Diabetic Products Customer D
|
|
|
537
|
|
|
|
528
|
|
|
|
9
|
|
All other Diabetic Products Customers
|
|
|
159
|
|
|
|
144
|
|
|
|
15
|
|
Totals
|
|
$
|
4,088
|
|
|
$
|
4,265
|
|
|
$
|
(177
|
)
|
Revenues from Diabetic
Products represented 88% of our net revenues in the 2020 Quarter compared to 89% of our net revenues in the 2019 Quarter.
Other Product Revenues
We design and sell
cases and protective solutions to OEMs for a diverse array of portable electronic devices (such as bar code scanners, GPS devices,
cellular phones, tablets and cameras), as well as a variety of other products (such as sporting and recreational products and firearms)
on a made-to-order basis that are customized to fit the products sold by our OEM customers.
Revenues from Other
Products increased approximately $31,000 to approximately $536,000 in the 2020 Quarter from approximately $505,000 in the 2019
Quarter. Notable fluctuations include an increase in sales to the following customers: An OEM handbag customer for $109,000, a
medical diagnostics company for $73,000, partially offset by a decline in sales to a sales and marketing customer for $60,000 and
other customers that were not material individually or in the aggregate. We will continue to focus on our sales and sales support
teams in our attempt to expand and diversify our Other Products customer base.
Revenues from Other
Products represented 12% of our net revenues in the 2020 Quarter compared to 11% of our net revenues in the 2019 Quarter.
Design Segment
Net revenues in the
design segment declined approximately $96,000, or 3%, to approximately $3.3 million in the 2020 Quarter from approximately $3.4
million in the 2019 Quarter. The following table sets forth our design segment net revenues by major customers for the 2020 Quarter:
|
|
(amounts in thousands)
|
|
|
|
2020
Quarter
|
|
|
2019
Quarter
|
|
|
Increase (Decrease)
|
|
Design Segment Customer A
|
|
$
|
452
|
|
|
$
|
789
|
|
|
$
|
(337
|
)
|
Design Segment Customer B
|
|
|
4
|
|
|
|
510
|
|
|
|
(506
|
)
|
Design Segment Customer C
|
|
|
540
|
|
|
|
271
|
|
|
|
269
|
|
Design Segment Customer D
|
|
|
–
|
|
|
|
49
|
|
|
|
(49
|
)
|
Design Segment Customer E
|
|
|
287
|
|
|
|
173
|
|
|
|
114
|
|
Design Segment Customer F
|
|
|
700
|
|
|
|
–
|
|
|
|
700
|
|
All other Design Segment Customers
|
|
|
1,324
|
|
|
|
1,611
|
|
|
|
(287
|
)
|
Totals
|
|
$
|
3,307
|
|
|
$
|
3,403
|
|
|
$
|
(96
|
)
|
Gross Profit
Distribution Segment
Gross profit for the
distribution segment declined approximately $191,000, or 25%, to approximately $561,000 in the 2020 Quarter from approximately
$752,000 in the 2019 Quarter as a result of a result of a shift to lower-margin cases and pricing pressures from customers. As
a percentage of revenues, our gross margin decreased to 12.8% in the 2020 Quarter from 15.8% in the 2019 Quarter. The decline in
margin in the 2020 Quarter from the 2019 Quarter is a result of pricing pressures and product mix weighing heavier on lower margin
diabetic cases.
Design Segment
Gross Profit for the
design segment increased approximately $333,000, or 60%, to approximately $892,000 in the 2020 Quarter from approximately $559,000
in the 2019 Quarter. Gross Profit as a percentage of revenue was 27% for the design segment for the 2020 Quarter compared to 16.4%
in the 2019 Quarter. Gross Profit percentage in the 2020 Quarter has been enhanced by result of efficient management of projects
and is closer to a normal run rate than the 2019 Quarter. The gross profit as a percentage of revenue for the 2019 Quarter was
significantly lower than historical performance for the design segment of our business as a result of project overruns for two
significant customers in the 2019 Quarter. Depreciation expense was approximately $28,000 and $22,000 for the 2020 Quarter and
2019 Quarter, respectively. Depreciation expense is allocated to Cost of Sales in the design segment.
Sales and Marketing
Expenses
Distribution Segment
Sales and marketing
expenses for the distribution segment increased approximately $76,000, or 24%, to approximately $391,000 in the 2020 Quarter from
approximately $315,000 in the 2019 Quarter. The increase was primarily due to the additional operating expenses related to the
pursuit of retail sales channels of approximately $101,000, partially offset by the reduction of an OEM salesperson and associated
expenses of approximately $54,000 in our Switzerland office. Management anticipates these selling expenses to rise as we gain more
traction in the retail outlets as commissions expense will increase, proportionally, and other related expenses will increase as
sales rise. Other fluctuations were not material individually or in the aggregate.
Design Segment
Sales and marketing
expenses for the design segment decreased approximately $16,000, or 5%, to approximately $129,000 in the 2020 Quarter from $113,000
in the 2019 Quarter. Sales and marketing expenses increased due to the addition of new sales representatives offset by a reduction
in sales commissions and sales promotions. Other fluctuations were immaterial individually and in the aggregate.
General and Administrative
Expenses
Distribution Segment
General and administrative
expenses in the distribution segment decreased approximately $465,000, to approximately $588,000 in the 2020 Quarter from approximately
$1,053,000 in the 2019 Quarter. This was primarily due to a decline in legal fees related to the SEC investigation of approximately
$251,000, which included an insurance settlement recovery of fees of approximately $80,000, a reduction in bad debt expense of
approximately $159,000, and a $94,000 reduction in Director’s share-based compensation. Fluctuations in other components
of “General and Administrative Expenses” were not material individually or in the aggregate.
Design Segment
General and administrative
expenses for the design segment increased approximately $132,000, or 15%, to $1,037,000 in the 2020 Quarter from approximately
$905,000 in the 2019 Quarter. The increase is driven by the investment impairment discussed in Note 4 of the Notes to Condensed
Consolidated Financial Statements of $327,000 partially offset by a reduction in bad debt expense of approximately $200,000. Fluctuations
in other components of “General and Administrative Expenses” were not material individually or in the aggregate.
Other Income (Expenses)
Distribution Segment
Other income (expenses)
for the distribution segment increased approximately $342,000 from approximately $35,000 in expense in the 2019 Quarter to $307,000
in income in the 2020 Quarter. This is due to net fair value adjustments of $341,000 to the purchase consideration components discussed
in Note 3 of the Notes to Condensed Consolidated Financial Statements.
Design Segment
Other income (expenses)
in the design segment decreased approximately $9,000 from $21,000 in expense in the 2019 Quarter to $12,000 in expense in the 2020
Quarter. This is composed of interest incurred on the line of credit and other debt instruments held within the design segment.
Income Taxes
For the three months
ended March 31, 2020, the Company generated a net loss of approximately $(1,371,000). The U.S. statutory tax rate for the fiscal
year ending September 30, 2020 is 21%. The Company maintains significant net operating loss carryforwards and does not recognize
income tax expense (benefit) as the Company’s deferred tax provision is offset by maintaining a full valuation allowance
on the Company’s net deferred tax asset.
RESULTS OF OPERATIONS
FOR THE SIX MONTHS ENDED MARCH 31, 2020 COMPARED TO THE SIX MONTHS ENDED MARCH 31, 2019
Net Income (Loss)
Distribution Segment
Distribution segment
net loss before taxes was approximately $(547,000) in the 2020 Period compared to net loss before taxes of approximately $(683,000)
in the 2019 Period. Net loss in the 2020 Period was primarily due to a reduction in sales and gross profit offset by a reduction
in operating expenses, as reflected in the table below.
Design Segment
Design segment net
loss before taxes was approximately $(906,000) in the 2020 Period compared to net loss before taxes of approximately $(979,000)
in the 2019 Period. Net loss in the 2020 Period was primarily due to the goodwill impairment loss of ($1,015,000) discussed in
Note 4 of the Notes to the Condensed Consolidated Statements of Operations, partially offset by an improvement in gross profit,
as reflected in the table below.
|
|
Main Components
of Net Loss
|
|
|
|
(amounts in thousands)
|
|
|
|
2020
Period
|
|
|
2019
Period
|
|
|
Increase
Decrease
|
|
|
|
Consolidated
|
|
|
Distribution
|
|
|
Design
|
|
|
Consolidated
|
|
|
Distribution
|
|
|
Design
|
|
|
Consolidated
|
|
Net revenues
|
|
$
|
16,324
|
|
|
$
|
9,320
|
|
|
$
|
7,004
|
|
|
$
|
18,355
|
|
|
$
|
11,050
|
|
|
$
|
7,305
|
|
|
$
|
(2,031
|
)
|
Gross profit
|
|
$
|
3,173
|
|
|
$
|
1,164
|
|
|
$
|
2,009
|
|
|
$
|
2,614
|
|
|
$
|
1,738
|
|
|
$
|
876
|
|
|
$
|
559
|
|
Less:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales and marketing expenses
|
|
|
1,014
|
|
|
|
742
|
|
|
|
272
|
|
|
|
899
|
|
|
|
640
|
|
|
|
259
|
|
|
|
115
|
|
General and administrative expenses
|
|
|
2,840
|
|
|
|
1,243
|
|
|
|
1,597
|
|
|
|
3,271
|
|
|
|
1,709
|
|
|
|
1,562
|
|
|
|
(431
|
)
|
Goodwill impairment
|
|
|
1,015
|
|
|
|
–
|
|
|
|
1,015
|
|
|
|
–
|
|
|
|
–
|
|
|
|
–
|
|
|
|
1,015
|
|
Operating income (loss)
|
|
|
(1,696
|
)
|
|
|
(821
|
)
|
|
|
(875
|
)
|
|
|
(1,556
|
)
|
|
|
(611
|
)
|
|
|
(945
|
)
|
|
|
(140
|
)
|
Other income (expenses)
|
|
|
243
|
|
|
|
274
|
|
|
|
(31
|
)
|
|
|
(106
|
)
|
|
|
(72
|
)
|
|
|
(34
|
)
|
|
|
349
|
|
Net income (loss)
|
|
$
|
(1,453
|
)
|
|
$
|
(547
|
)
|
|
$
|
(906
|
)
|
|
$
|
(1,662
|
)
|
|
$
|
(683
|
)
|
|
$
|
(979
|
)
|
|
$
|
209
|
|
Basic and diluted loss per share were $(0.15)
per share for the 2020 Period and $(0.17) per share for the 2019 Period.
Net Revenues
Distribution Segment
Net revenues in the
distribution segment declined approximately $1.7 million, or 16%, to $9.3 million in the 2020 Period from approximately $11 million
in the 2019 Period primarily as a result of decreased Diabetic product line revenue in addition to a smaller decline in Other product
line revenue. The following tables set forth revenues by channel, product line and geographic location of our Distribution segment
customers for the periods indicated:
|
|
Net Revenues for 2020 Period
|
|
|
|
(amounts in thousands)
|
|
|
|
EMEA
|
|
|
APAC
|
|
|
Americas
|
|
|
Total
|
|
Diabetic products
|
|
$
|
3,141
|
|
|
$
|
2,460
|
|
|
$
|
2,667
|
|
|
$
|
8,268
|
|
Other products
|
|
|
95
|
|
|
|
322
|
|
|
|
635
|
|
|
|
1,052
|
|
Total net revenues
|
|
$
|
3,236
|
|
|
$
|
2,782
|
|
|
$
|
3,302
|
|
|
$
|
9,320
|
|
|
|
Net Revenues for 2019 Period
|
|
|
|
(amounts in thousands)
|
|
|
|
EMEA
|
|
|
APAC
|
|
|
Americas
|
|
|
Total
|
|
Diabetic products
|
|
$
|
3,638
|
|
|
$
|
3,310
|
|
|
$
|
2,665
|
|
|
$
|
9,613
|
|
Other products
|
|
|
80
|
|
|
|
732
|
|
|
|
625
|
|
|
|
1,437
|
|
Total net revenues
|
|
$
|
3,718
|
|
|
$
|
4,042
|
|
|
$
|
3,290
|
|
|
$
|
11,050
|
|
Diabetic Product Revenues
Forward’s distribution
segment manufactures to the order of, and sells carrying cases for blood glucose diagnostic kits directly to OEMs (or their contract
manufacturers). The OEM customer or its contract manufacturer packages our carry cases “in box” as a custom accessory
for the OEM’s blood glucose testing and monitoring kits, or to a lesser extent, sells them through their retail distribution
channels.
Revenues from Diabetic
Products declined approximately $1.3 million, or 14%, to approximately $8.3 million in the 2020 Period from approximately $9.6
million in the 2019 Period. This decline was primarily due to lower revenues from three major Diabetic Products customers, Diabetic
Products customers B, C and D, partially offset by a rise in sales to all other Diabetic Products customers. Management believes
that revenues from diabetic customers will continue to decline.
The following table
sets forth our distribution segment net revenues by Diabetic Products customer for the periods indicated:
|
|
(amounts in thousands)
|
|
|
|
2020
Period
|
|
|
2019
Period
|
|
|
Increase (Decrease)
|
|
Diabetic Products Customer A
|
|
$
|
3,316
|
|
|
$
|
3,318
|
|
|
$
|
(2
|
)
|
Diabetic Products Customer B
|
|
|
2,201
|
|
|
|
3,172
|
|
|
|
(971
|
)
|
Diabetic Products Customer C
|
|
|
1,577
|
|
|
|
1,687
|
|
|
|
(110
|
)
|
Diabetic Products Customer D
|
|
|
770
|
|
|
|
1,137
|
|
|
|
(367
|
)
|
All other Diabetic Products Customers
|
|
|
405
|
|
|
|
299
|
|
|
|
106
|
|
Totals
|
|
$
|
8,269
|
|
|
$
|
9,613
|
|
|
$
|
(1,344
|
)
|
Revenues from Diabetic
Products represented 89% of our net revenues in the 2020 Period compared to 87% of our net revenues in the 2019 Period.
Other Product Revenues
We design and sell
cases and protective solutions to OEMs for a diverse array of portable electronic devices (such as bar code scanners, GPS devices,
cellular phones, tablets and cameras), as well as a variety of other products (such as sporting and recreational products and firearms)
on a made-to-order basis that are customized to fit the products sold by our OEM customers.
Revenues from Other
Products declined approximately $385,000 to $1.05 million in the 2020 Period from $1.44 million in the 2019 Period. The decline
is due to a decrease in sales of approximately $159,000 to a new temperature-monitoring device customer (through a divisional cross-selling
opportunity), a decrease of approximately $146,000 to an electronics manufacturing conglomerate customer, partially offset by an
increase in sales of approximately $132,000 to a medical diagnostics company, increase in sales of approximately $128,000 to a
retail customer, and an increase in sales of approximately $109,000 to an OEM handbags customer. Fluctuations in sales to other
customers were not individually material. We will continue to focus on our sales and sales support teams in our attempt to expand
and diversify our Other Products customer base.
Revenues from Other
Products represented 11% of our net revenues in the 2020 Period compared to 13% of our net revenues in the 2019 Period.
Design Segment
Net revenues in the
design segment declined approximately $300,000, or 4%, to $7.0 million in the 2020 Period from approximately $7.3 million in the
2019 Period. The following table sets forth our design segment net revenues by major customers for periods indicated:
|
|
(amounts in thousands)
|
|
|
|
2020
Period
|
|
|
2019
Period
|
|
|
Increase (Decrease)
|
|
Design Segment Customer A
|
|
$
|
1,297
|
|
|
$
|
1,395
|
|
|
$
|
(98
|
)
|
Design Segment Customer B
|
|
|
12
|
|
|
|
690
|
|
|
|
(678
|
)
|
Design Segment Customer C
|
|
|
898
|
|
|
|
791
|
|
|
|
107
|
|
Design Segment Customer D
|
|
|
–
|
|
|
|
859
|
|
|
|
(859
|
)
|
Design Segment Customer E
|
|
|
746
|
|
|
|
297
|
|
|
|
449
|
|
Design Segment Customer F
|
|
|
1,083
|
|
|
|
–
|
|
|
|
1,083
|
|
All other Design Segment Customers
|
|
|
2,968
|
|
|
|
3,273
|
|
|
|
(305
|
)
|
Totals
|
|
$
|
7,004
|
|
|
$
|
7,305
|
|
|
$
|
(301
|
)
|
Gross Profit
Distribution Segment
Gross profit for the
distribution segment declined approximately $574,000, or 33%, to approximately $1.2 million in the 2020 Period from approximately
$1.7 million in the 2019 Period as a result of a shift to lower-margin cases and pricing pressures from customers. As a percentage
of revenues, our gross margin decreased to 12.5% in the 2020 Period from 15.7% in the 2019 Period. We are working on expanding
our product offering to include higher margin products as well as enhancing our sales efforts to raise top side gross sales to
raise total gross profit.
Design Segment
Gross Profit for the
design segment increased approximately $1.1 million from approximately $876,000 in the 2019 Period to approximately $2.0 million
in the 2020 Period. Gross Profit improved as a percentage of revenue from 12.0% in the 2019 Period to 28.7% in the 2020 Period.
The gross profit as a percentage of revenue for the 2019 Quarter is significantly lower than historical performance for the design
segment of our business. The decline was the result of project overruns on two significant customers in the 2019 Period. Depreciation
expense was approximately $54,000 in the 2020 Period and $70,000 for the 2019 Period. Depreciation expense is allocated to Cost
of Sales in the design segment.
Sales and Marketing
Expenses
Distribution Segment
Sales and marketing
expenses for the distribution segment increased approximately $102,000, or 16%, to approximately $742,000 in the 2020 Period from
approximately $640,000 in the 2019 Period. The increase was primarily due to the additional $252,000, approximately, in operating
expenses related to the pursuit of retail sales channels partially offset by a reduction of approximately $105,000 in expenses
related to the reduction of a salesperson in our Switzerland sales office. Other fluctuations were not material individually or
in the aggregate.
Design Segment
Sales and marketing
expenses for the design segment increased nominally by $13,000, or 5%, from $259,000 in the 2019 Period to $272,000 in the 2020
Period. Sales and marketing expenses increased due to the addition of new sales representatives for $37,000 offset by a reduction
in sales commissions and sales promotions of $29,000. Other fluctuations were immaterial individually and in the aggregate.
General and Administrative
Expenses
Distribution Segment
General and administrative
expenses in the distribution segment declined approximately $466,000, or 27%, to approximately $1.24 million in the 2020 Period
from approximately $1.71 million in the 2019 Period, was primarily due to a decline in legal fees related to the SEC investigation
of approximately $251,000, which included an insurance settlement recovery of fees of approximately $80,000, a reduction in bad
debt expense of approximately $159,000, and a $64,000 reduction in Director’s share-based compensation. Fluctuations in other
components of “General and Administrative Expenses” were not material individually or in the aggregate.
Design Segment
General and administrative
expenses for the design segment were approximately $1,597,000 for the 2020 Period. General and administrative expenses in the design
segment increased nominally by approximately $35,000 from $1,562,000 for the 2019 Period. The nominal increase is a mix of fluctuations
including the investment impairment discussed in Note 3 of the Notes to Condensed Consolidated Financial Statements of $327,000.
The offset is driven a reduction in bad debt expense of approximately $359,000. Fluctuations in other components of “General
and Administrative Expenses” were not material individually or in the aggregate.
Other Income (Expenses)
Distribution Segment
Other income (expenses)
for the distribution segment increased approximately $346,000 from approximately $72,000 in expense in the 2019 Period to $274,000
in income in the 2020 Period. This is primarily due to net fair value adjustments of $341,000 to the purchase consideration components
discussed in Note 3 of the Notes to Condensed Consolidated Financial Statements.
Design Segment
Other expenses in
the design segment were approximately $31,000 for the 2020 Period. Other expenses in the design segment for the 2019 Period were
approximately $34,000. This is composed of interest incurred on the line of credit and other debt instruments held within the design
segment.
Income Taxes
For the six months
ended March 31, 2020, the Company generated a net loss of approximately ($1,453,000). The U.S. statutory tax rate for the fiscal
year ended September 30, 2020 is 21%. The Company maintains significant net operating loss carryforwards and does not recognize
income tax expense (benefit) as the Company’s deferred tax provision is typically offset by maintaining a full valuation
allowance on the Company’s net deferred tax asset.
LIQUIDITY AND CAPITAL
RESOURCES
Our primary source
of liquidity is our operations. The primary demand on our working capital has historically been (i) operating losses, (ii) repayment
of debt obligations, and (iii) any increases in accounts receivable and inventories arising in the ordinary course of business.
Historically, our sources of liquidity have been adequate to satisfy working capital requirements arising in the ordinary course
of business.
As of the filing date
of this report, we had $300,000 available under our $1.3 million line of credit which matures August 29, 2020. The Company has
paid down the line of credit using available cash from operations. Recently, the maturity date on the $1.6 million Forward China
promissory note was extended to July 17, 2020 (see Note 9 – Related Party Transactions). Although this note has been extended
on multiple occasions to assist the Company with its liquidity position, we plan on funding the repayment at maturity using existing
cash balances and/or obtaining an additional credit facility as deemed necessary.
As discussed in Note
15 – Subsequent Events, on April 18, 2020, the Company entered into a loan with TD Bank, N.A. in an aggregate principal
amount of approximately $1.4 million under the Paycheck Protection Program (the “PPP Loan”) pursuant to the recently
enacted U.S. Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”). This loan is unsecured, and the
Company will apply for forgiveness of the PPP Loan in accordance with the terms of the CARES Act. We can provide no assurance
that we will be successful in obtaining forgiveness for the PPP Loan.
We anticipate that
our liquidity and financial resources for Forward and the consolidated subsidiaries for the next 12 months from the date of the
filing of this Form 10-Q will be adequate to manage our operating and financial requirements. If we have the opportunity to make
a strategic acquisition or to make an investment in a product or partnership, we will require additional capital beyond our current
cash balance to fund the opportunity. If we seek to raise additional capital, there is no assurance that we will be able to raise
funds on terms that are acceptable to us or at all.
At March 31, 2020,
our current ratio (current assets divided by current liabilities) was 1.5 compared to 1.4 at September 30, 2019; At March 31, 2020,
our quick ratio (current assets less inventories divided by current liabilities) was 1.4 compared to 1.2 at September 30, 2019;
At March 31, 2020, our working capital (current assets less current liabilities) was approximately $3.5 million compared to $3.5
million at September 30, 2019. As of June 5, 2020, we had approximately $3.5 million of cash on hand.
Although we do not
anticipate the need to purchase additional material capital assets in order to carry out our business, it may be necessary for
us to purchase equipment and other capital assets in the future, depending on need.
During the six months
ended March 31, 2020 and 2019, our sources and uses of cash were as follows:
Cash Flows from
Operating Activities
During the 2020 Period,
cash used in operating activities of approximately $554,000 resulted from a net loss of $1,453,000, an increase in accounts receivable
of approximately $564,000, a decrease in accounts payable of approximately $986,000, a decrease in lease liabilities of approximately
$139,000, an increase in prepaid expenses and other current assets of approximately $168,000, a decline in accrued expenses and
other current liabilities of $33,000, partially offset by a decline in inventories of approximately $973,000, an increase of deferred
income of approximately $488,000, a decline in other assets of approximately $71,000, in addition to the add-backs for depreciation
and amortization of approximately $297,000 and share-based compensation of approximately $69,000, bad debt recovery of approximately
$110,000 and a non-cash impairment to goodwill of $1,015,000, a non-cash impairment of investment of approximately $327,000, and
a non-cash decrease of $341,000 in fair value adjustments of the earn-out consideration and deferred cash consideration.
During the 2019 Period,
cash used in operating activities of approximately $2.8 million resulted primarily from a net loss of approximately $1.66 million,
a decrease of Accounts Payable (including due to Forward China) of approximately $2.06 million, an increase in prepaid expenses
and other assets of approximately $643,000, a decrease in deferred income of approximately $54,000, partially offset by a decline
in accounts receivable of approximately $795,000, a reduction of inventory of approximately $136,000, a reduction of accrued expenses
of approximately $11,000, in addition to the add-backs for bad debt expense of approximately $408,000, share-based compensation
of approximately $148,000, depreciation and amortization of approximately $157,000, and the add-back of deferred rent of approximately
$2,000.
Cash Flows from
Investing Activities
In the 2020 Period,
cash used in investing activities of approximately $27,000 resulted from purchases of property and equipment.
In the 2019 Period,
cash used in investing activities of approximately $24,000 resulted from purchases of property and equipment.
Cash Flows from
Financing Activities
In the 2020 Period,
cash used in financing activities of approximately $1,163,000 consisted of $1,100,000 in repayments on the line of credit, offset
by $200,000 in borrowings on the line of credit, $200,000 paid out on the deferred cash consideration, approximately $47,000 in
repayments on notes payable and approximately $16,000 in repayments on capital equipment leases.
In the 2019 Period,
cash provided by financing activities of approximately $804,000 consisted of $1,250,000 in borrowings on the line of credit, offset
by $300,000 in repayments on the line of credit, approximately $121,000 in repayments on notes payable and approximately $25,000
in repayments on capital equipment leases.
Related Party Transactions
For information on
related party transactions and their financial impact, see Note 9 to the unaudited condensed consolidated financial statements
contained herein.
Cautionary Note Regarding Forward-Looking
Statements
This report contains
“forward-looking statements”, as such term is used within the meaning of the Private Securities Litigation Reform Act
of 1995, including statements regarding our liquidity, expectations regarding the impact of the pandemic on our business, expectations
regarding the length of pandemic’s business disruption, expectations regarding the forgiveness of the PPP Loan, beliefs regarding
the design segments future results of operations, anticipated distribution of products from the Mooni distribution agreement, plans
regarding the repayment of debt and beliefs regarding our capital. Forward-looking statements can be identified by words such as
“anticipates,” “intends,” “plans,” “seeks,” “believes,” “estimates,”
“expects” and similar references to future periods. Forward-looking statements are based on our current expectations
and assumptions regarding our business, the economy and other future conditions. Because forward-looking statements relate to the
future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Our actual
results may differ materially from those contemplated by the forward-looking statements. We caution you therefore against relying
on any of these forward-looking statements. They are neither statements of historical fact nor guarantees or assurances of future
performance. Important factors that could cause actual results to differ materially from those in the forward-looking statements
include the failure to receive material orders, our ability to successfully market and sell products that we develop, the effects
of the COVID-19 outbreak, including levels of consumer, business and economic confidence generally, the duration of the COVID-19
outbreak and severity of such outbreak, the pace of recovery following the COVID-19 outbreak, the effect on our supply chain, our
ability to implement cost containment; and the adverse effects of the COVID-19 outbreak on our business or the market price of
our common stock, failure to diversify the industries in which we sell our products, potential imposed tariffs or other restrictions
placed on imports by the U.S. government, and continued pricing pressure on our products. Further information on our risk factors
is contained in our filings with the SEC, including our Form 10-K for the year ended September 30, 2019. Any forward-looking statement
made by us speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may
emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any
forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required
by law.